Patriot Transportation

Patriot Transportation Holding Inc is a regional tank truck carrier in North America. Its business consists of hauling petroleum-related products and dry bulk commodities and liquid chemicals. The company currently has over eighteen terminal and satellite locations spread across the states of Florida, Georgia, Alabama, and Tennessee. The company also provides the delivery service in the liquid chemical and dry bulk business primarily from distribution facilities or manufacturing facilities to the end-user.

Patriot Transportation Holding, Inc. - Common Stock

PATIENT ACCESS SLTNS INC by Patient Access Solutions, Inc.

Patient Access Solutions

PATIENT PORTAL TECHS INC by Patient Portal Technologies, Inc.

Patient Portal

WIIM

Lydall shares are trading higher after Unifrax announced it has signed definitive agreements to acquire Lydall for $61.10 per share.

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">99.97</td>
<td align="right">0.36</td>
<td align="right">0.36</td>
<td>26.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">35.35</td>
<td align="right">0.12</td>
<td align="right">0.34</td>
<td>1.5 million</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">80.99</td>
<td align="right">0.25</td>
<td align="right">0.30</td>
<td>22.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">78.70</td>
<td align="right">0.12</td>
<td align="right">0.15</td>
<td>433</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">172.30</td>
<td align="right">0.14</td>
<td align="right">0.08</td>
<td>1.2K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">63.69</td>
<td align="right">-0.41</td>
<td align="right">-0.64</td>
<td>5.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">52.19</td>
<td align="right">-0.20</td>
<td align="right">-0.39</td>
<td>158.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">68.60</td>
<td align="right">-0.20</td>
<td align="right">-0.30</td>
<td>27.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">123.61</td>
<td align="right">-0.13</td>
<td align="right">-0.11</td>
<td>3.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">44.31</td>
<td align="right">-0.02</td>
<td align="right">-0.05</td>
<td>5.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">142.02</td>
<td align="right">-0.07</td>
<td align="right">-0.05</td>
<td>12.0K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> these sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors.
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For June 21, 2021

News

Dividends

Saga Communications Reports Resumption Of Qtr. Dividend, Will Begin At $0.16/Share

Eos Energy Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) (&quot;Eos&quot;), a leading provider of safe, scalable, efficient, and sustainable zinc-powered energy storage systems, today announced it will join the broad-market Russell 3000&reg; Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. 
&nbsp;
The annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 7, ranking them by total market capitalization. Membership in the US all-cap Russell 3000&reg; Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000&reg; Index or small-cap Russell 2000&reg; Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
&quot;The inclusion of Eos in the Russell 3000&reg; Index marks an exciting milestone for our company and is a testament to the market reception to our technology and the tremendous opportunity we have in front of us,&quot; said Sagar Kurada, Chief Financial Officer of Eos. &quot;We are pleased to be listed among the distinguished companies in the Russell indexes and look forward to deeper engagement with investors and other key stakeholders.&quot;
Eos is a leading manufacturer of long duration (3-12 hour) energy storage solutions featuring its proprietary Zynth&reg; technology. This zinc-powered battery addresses the variability of renewable energy sources by providing reliable power to applications across the energy supply chain, including utilities, and industrial and commercial sites. Eos&#39;s Pittsburgh-based manufacturing facility, suite of support services and majority domestically sourced supply chain, enable it to scale up its production to serve the needs of customers and communities around the world. In its&nbsp;Q1&nbsp;earnings call, Eos reported more than 200 MWh of orders backlog and 265 MWh of discharged energy, equating to approximately 2 million operating cycles since 2016.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately&nbsp;$10.6 trillion&nbsp;in assets are benchmarked against Russell&#39;s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.
For more information on the Russell 3000&reg;&nbsp;Index and the Russell indexes reconstitution, please visit the &quot;Russell Reconstitution&quot; section on the&nbsp;<a href="https://www.globenewswire.com/Tracker?data=o1410J_qns8KTniLub8JLvWVFnX3k46KQqcPqmFC5PaOoJI7hPgxMLl6OwhJwcR7Cy-fLu_KM2WtmxUFrlAEGesxBaNg8EsfFvIst7i5cqI9x30XBbd4nuZzfI3PqIRws0i6K9zCgdwYrtDHvTdiVw==" target="_blank">FTSE Russell website</a>.

EOSE

Eos Energy Enterprises To Be Included In Russell 3000 Index On June 28

Citigroup maintains American Intl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) with a Neutral and raises the price target from $48 to $51.

Price Target

Analyst Ratings

Citigroup Maintains Neutral on American Intl Gr, Raises Price Target to $51

Prometheus Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXDX#NASDAQ">RXDX</a>), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, starting first with inflammatory bowel disease (IBD), today announced it has received a&nbsp;$10 million&nbsp;milestone payment from Dr. Falk Pharma GmbH under its collaboration agreement to develop and commercialize Prometheus&#39; second program, PR600. Prometheus has selected a clinical candidate for PR600, targeting an undisclosed member of the tumor-necrosis factor superfamily for the treatment of IBD and is initiating IND-enabling studies.
&quot;Partnering with Dr. Falk on PR600 has enabled us to accelerate the PR600 program by sharing costs, resources, and drug development know-how, which has resulted in the achievement of this important milestone within the first year of our collaboration,&quot; said Mark McKenna, President and CEO of Prometheus. &quot;We expect to file an Investigational New Drug Application for PR600 in the&nbsp;third quarter&nbsp;of 2022 and plan to explore its utility in other immune-mediated indications beyond IBD.&quot;
Under the collaboration agreement, which was executed in July 2020, Prometheus and Dr. Falk will share responsibility for the global development of PR600, with Dr. Falk contributing a certain portion of the external development costs associated with PR600 and its companion diagnostic. Dr. Falk acquired exclusive rights to commercialize PR600 in Europe, Australia and New Zealand, and Prometheus retains exclusive rights to commercialize PR600 in the United Stated and rest of world.

Contracts

RXDX

Prometheus Biosciences Says Achieves Milestone Payment Of $10M From Dr. Falk Pharma GmbH

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3202327-1&amp;h=3581216705&amp;u=https%3A%2F%2Fwww.synopsys.com%2F&amp;a=Synopsys%2C+Inc." target="_blank">Synopsys, Inc.</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snps#NASDAQ">SNPS</a>) today announced that it has signed a definitive agreement to acquire the semiconductor and flat panel display solutions from BISTel, a leader in engineering equipment systems and AI applications for semiconductor smart manufacturing, headquartered in South Korea. When completed, the acquisition will broaden Synopsys&#39; industry-leading process control solutions for semiconductor fabs with an integrated and comprehensive yield management and prediction solution to enhance manufacturing quality and efficiency. The acquisition will also add a team of experienced engineers to accelerate technology development using real-time manufacturing predictive analysis.
The transaction is subject to customary closing conditions and is expected to close in Synopsys&#39; fourth quarter of fiscal year 2021. The terms of the deal, which are not material to Synopsys&#39; financials, are not being disclosed.
&quot;Semiconductor fabs are rising to the challenge of meeting market demand for products that drive the global economy,&quot; said Howard Ko, general manager of the Silicon Engineering Group at Synopsys. &quot;Combining Synopsys&#39; and BISTel&#39;s expertise in fab solutions will enable us to bring to market innovative process control products that help our customers maximize their economic opportunity.&quot;

SNPS

Synopsys Reports Will Buy Semi, Flat Panel Display Solutions From BISTel, No Terms Disclosed

Demonstrates better anti-metastatic activity compared with docetaxel alone
Company to host webcast on its oncology program today at 11:00 a.m. ET
MONTREAL, June 21, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TH#TSX">TH</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THTX#NASDAQ">THTX</a>), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced new preclinical in vivo findings on the anti-metastatic effect and tolerability of its novel investigational proprietary peptide-drug conjugate (PDC), TH1902.
These results demonstrate that TH1902 has better anti-metastatic activity when compared to docetaxel alone when administered at an equimolar concentration in a lung metastasis cancer model expressing the sortilin (SORT1) receptor.&nbsp;&nbsp; Metastasis is a form of cancer that has spread from its original site to a distant site or organ where it grows or metastasizes. It is well-known that the survival rate for metastatic cancer is low. The Company intends to present these findings at an upcoming scientific meeting.&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;
&ldquo;These new results are very encouraging for the development of TH1902 in SORT1+ cancers. It is known that SORT1-receptor expression increases as cancers progress and these new data confirm that by targeting the SORT1 receptor TH1902 could potentially be effective in the treatment of metastasis.&nbsp;&nbsp; Most importantly, these preclinical findings, if confirmed in humans, are promising signs that we may finally be able to inhibit hard-to-treat cancers with a more effective and better-tolerated treatment,&rdquo; said Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer of Theratechnologies.
The Company will host a webcast today at 11:00 a.m. ET to discuss its SORT1+ Technology and TH1902, which will include additional details on these preclinical findings. To access the live webcast please click <a href="https://www.globenewswire.com/Tracker?data=bt5wU3UeuOZtFlocuFFOeilR4sDlAhLRknmZk7d4Ap_bpMgiBv5aLnUCKM-WOD6QCzguUY7aGqBlM8uB48ij_InSR1u0jNc-UrmtB8ZSu2qCe6kj0wOxi2_WA1StYBNc_98rmKUPIYq6qJo5qEOvu1fZypV4SZAklA7q6oaECh8=" target="_blank">here</a>. An archived webcast will also be available on the Company&rsquo;s website under the &lsquo;<a href="https://www.globenewswire.com/Tracker?data=mhdMCKk3pVW6Ob7OJdPbznZycAUYL_ZOb1PweJPRxJ9-FWVU9-YNZfY5MYn6zweoyvsA1JcAzWjv6HqRRKJUs2tX8rfVpeFjgeJ8Gi5LjSlJmO0gEEzl5e_mTkT-l7wS" target="_blank">Past Events</a>&rsquo; section.

THTX

TSX:TH

Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers

&nbsp;Infrastructure and Energy Alternatives, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEA#NASDAQ">IEA</a>) (&quot;IEA&quot; or the &quot;Company&quot;), a leading infrastructure construction company with renewable energy and specialty civil expertise, today announced that the Company is set to join the broad-market Russell 3000&reg;&nbsp;Index as part of this year&#39;s rebalance according to a preliminary list of additions posted on June 4, 2021. The change will become effective one week from today after the market opens on Monday, June 28, 2021. 
&nbsp;
FTSE Russell determines membership for its Russell indices based on objective, market-capitalization rankings and style attributes. This year&#39;s reconstitution captured the 4,000 largest U.S. stocks as of May 7th, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000&reg;&nbsp;Index, which remains in place for one year, provides automatic inclusion in the large-cap Russell 1000&reg;&nbsp;Index or small-cap Russell 2000&reg;&nbsp;Index as well as the appropriate growth and value style indexes. IEA will be added to the Russell 2000&reg;&nbsp;Index as well.
&quot;We are very pleased that IEA has been added to the Russell 3000 Index,&quot; said JP Roehm, IEA&#39;s President and Chief Executive Officer. &quot;We anticipate our addition to the index will create increased awareness of the Company and our stock across the investment community.&quot;
Russell indices are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately&nbsp;$10.6 trillion&nbsp;in assets are benchmarked against Russell&#39;s U.S. indices. Russell indices are part of FTSE Russell, a leading global index provider.
The &quot;Russell Reconstitution&quot; section on the&nbsp;<a href="https://www.globenewswire.com/Tracker?data=ylZbFOCIfTGrCrQNhIbRo5lP3O_8pS73tNegqb1B2eC3jdf_GFwgFLURLAuhSDQKpKYDiVd99x8Si6jW2eTSTQmyM45EYhp31jnYa7zl7DJ_h817299z2Jw3Uj7L3Gn_tCdBul5FGubtLgk-SLX83A==" target="_blank">FTSE Russell website</a>&nbsp;provides information on the Russell 3000&reg;&nbsp;Index and the Russell index reconstitution.

Infrastructure And Energy Alternatives To Be Added To Russell 3000 Index On June 28

Deal to Add Long-Term Acute Care Hospitals to Company&#39;s National Post-Acute Network
MECHANICSBURG, Pa., June 21, 2021 /PRNewswire/ --&nbsp;Select Medical today announced it has signed a definitive agreement to acquire Charlotte, NC-based Acuity Healthcare.&nbsp; The purchase will include four long-term acute care hospitals and one satellite serving communities in New Jersey and West Virginia.&nbsp; The deal also includes the establishment of four joint venture (JV) partnerships with AtlantiCare, Mon Health, Virtua Health and&nbsp; physician partners.&nbsp;
&quot;This agreement represents Select Medical&#39;s continued focus to execute strategic joint ventures as part of its growth strategy,&quot; said Tom Mullin, executive vice president and chief operating officer of specialty hospitals at Select Medical.&nbsp; &quot;Together, with our new partners, we look forward to serving the specialty care needs of chronic, critically ill patients in these emergent regions.&quot;
Through the agreement, Select Medical&#39;s national network of critical illness recovery hospitals, licensed as long-term acute care, will expand to 104 locations.&nbsp; The Acuity hospitals to be acquired will be renamed Select Specialty Hospital and remain in current New Jersey and West Virginia locations.&nbsp;&nbsp;
<ul>
<li>Select Specialty Hospital &ndash; Willingboro, NJ &ndash; Virtua Health JV partner</li>
<li>Select Specialty Hospital &ndash; Atlantic City, NJ &ndash; AtlantiCare JV partner</li>
<li>Select Specialty Hospital &ndash; Morgantown, WV &ndash; Mon Health JV partner</li>
<li>Select Specialty Hospital &ndash; Weirton, WV &ndash; Physician JV partners</li>
<li>Select Specialty Hospital &ndash; Wheeling, WV (Satellite Location) &ndash; Physician JV partners</li>
</ul>
&quot;The joint venture partnership with Select Medical brings the clinical excellence and best practices of the nation&#39;s No. 1 post-acute care provider to the regions we currently serve,&quot; said Ed Cooper, president and chief executive officer at Acuity Healthcare. Select Medical shares our common mission to build healthy communities and improve quality of life for the patients and families they serve. As the aging population continues to grow, the need for continued long-term acute care to treat chronic, critically ill patients has become an essential service and they are well-positioned to handle the future changes facing healthcare and the post-acute industry.&quot;
The deal is expected to close in Q3 2021, subject to regulatory approval.

Select Medical Reports Deal To Buy Acuity Healthcare, No Terms Disclosed; Enters Joint Venture Partnerships With AtlantiCare, Mon Health, Virtua Health, Physician Partners

PRVA

Privia Health to be Added to Russell 2000 Index

Select Medical Reports Purchase Of Curahealth Tucson, No Terms Disclosed

Real Estate to be Sold Separately 
Part of Execution of Company&#39;s Monetization Plan
HOUSTON, June 21, 2021 /PRNewswire/ --&nbsp;Luby&#39;s, Inc. (&quot;Luby&#39;s&quot; or the &quot;Company&quot;) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUB#NYSE">LUB</a>) today announced the Company has entered into an agreement to sell the Luby&#39;s Cafeteria restaurant business to a newly formed affiliate of Calvin Gin.&nbsp;
The purchase by the Gin affiliate (to be renamed Luby&#39;s Restaurants Corporation following closing of the transaction) will include 32 of the existing locations of Luby&#39;s restaurants, all in Texas (listed below), and ownership of the Luby&#39;s Cafeteria brand. The acquisition of the Luby&#39;s cafeterias business does not include any of the real estate owned by Luby&#39;s, nor does it include any of the Company&#39;s Fuddruckers operations1 or the Company&#39;s Culinary Contract Service business. The structure of the transaction will allow Luby&#39;s to sell its real estate related to its cafeteria restaurant business to third parties and realize the related value for its shareholders. It is currently anticipated, following the closing of the transaction, that almost all employees at the 32 involved locations will be offered positions by the purchaser to remain at those store locations, employment that will likely total over 1,000 associates. It is currently anticipated that the Luby&#39;s Cafeteria operations sale transaction could provide Luby&#39;s with approximately $28.7 million of value (all but a nominal amount of which will be derived from the purchaser&#39;s assumption of Luby&#39;s liabilities and the purchaser&#39;s issuance of notes to Luby&#39;s). There can be no assurance that the Company will realize or receive the full value of such consideration. The Company does not currently plan to adjust the estimated liquidation value of the Company as a result of this transaction. This&nbsp;amount does not include any value that may be obtained through future sales of Luby&#39;s owned real estate underlying 25 of the cafeteria locations.
Mr. Gin, Chief Executive Officer of the purchaser, commented, &quot;We are so pleased to be able to acquire the operation of these Luby&#39;s Cafeteria stores, one of the iconic brands in the Texas restaurant market. This transaction will allow us to continue serving the many loyal Luby&#39;s customers at these locations and to provide long-term employment opportunities for the many associates currently at these locations.&quot;
Gerald Bodzy, Chairman of the Board of Luby&#39;s, commented, &quot;I could not be more pleased than to see Calvin Gin, along with many of the existing management team, able to carry on the fine tradition of Luby&#39;s brand of food and service in Texas that dates back to 1947.&quot;
The sale of the Luby&#39;s Cafeteria operations is another step in the execution of the previously announced plan of Luby&#39;s to sell its assets, pay its liabilities, and return the remaining cash to shareholders under the Company&#39;s previously announced plan of liquidation and dissolution approved by its shareholders on November 17, 2020. The Company and its financial advisor ran a robust sales process for the Luby&#39;s Cafeteria business, contacting over 235 entities before accepting the best offer, which came from the Gin group. Luby&#39;s is actively engaged in attempting to monetize the real estate it owns that is related to its cafeteria restaurant business, including the 25 properties the Company intends to sell to a third party or parties that can, in turn, provide the purchaser operating leases for those properties. The purchaser will also assume the leases for seven Luby&#39;s locations that are currently under lease. Luby&#39;s is being advised by Jones Lang LaSalle on these real estate sales. The Special Committee of the Board of the Company is being advised by Gibson, Dunn &amp; Crutcher LLP on legal matters. The Company is also being advised by Sidley Austin LLP on legal transaction matters. The purchaser is being advised by Winston &amp; Strawn LLP on legal matters.
The agreement between Luby&#39;s and the purchaser is subject to normal and customary conditions for transactions of this nature. The transaction is not subject to a financing contingency. The parties currently anticipate the transaction will close before the end of the Company&#39;s current fiscal year.

Asset Sales

Luby's To Sell Luby's Cafeteria Restaurant Operations To Affiliate Of Calvin Gin, Sees Deal Valued At $28.7M

Trading Ideas

Lydall Shares Resume Trading, Spike Higher

AIM ImmunoTech Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIM#NYSE">AIM</a>) today announced that all subjects have completed treatment in the Company&#39;s Phase 1 clinical study to assess the safety, tolerability and biological activity of Ampligen as a potential intranasal therapy. A final study report is expect in the&nbsp;third quarter&nbsp;of 2021. 
&nbsp;
A total of 40 healthy subjects received either Ampligen or a placebo in the trial, with the Ampligen given at four escalating dosages across four cohorts, to a maximum level of 1,250 micrograms. The study reported no Severe Adverse Events at any dosage level.
With these positive preliminary results in hand, the Company is now moving forward with the initial planning and negotiations for a follow-up Phase 2 study testing Ampligen as a potential broad-spectrum respiratory virus prophylaxis. Unlike other drugs tailored to combat specific diseases, Ampligen targets and amplifies the natural immune system pathways that fight viruses, meaning that Ampligen delivered via an intranasal device could be an effective preventive therapy for people who may be exposed to, or have recently been exposed to, a respiratory virus such as influenza, or even common coronaviruses and rhinoviruses (like the common cold). This Phase 2 study will test this proposition in humans. A successful Phase 2 study could also establish Ampligen as a potential prophlyaxis against future viral variants and future novel respiratory viruses for which there are no current therapies. Moreover, an Ampligen prophylaxis could potentially benefit vulnerable populations who are at increased risk of transmission due to their environments, such as hospital workers; people on cruises, cargo or miltary ships; people on commercial airplanes; and service personnel in close quarters on military installations.

AIM ImmunoTech Says Completes All Treatments In Phase 1 Human Safety Study Of Intranasal Administration Of Ampligen

Select Medical, Scripps Health and UC San Diego Health today announced they have entered a joint venture partnership to serve the unmet post-acute critical illness recovery care needs of San Diego and surrounding communities.&nbsp; For Select Medical and UC San Diego Health, the agreement is an extension of an existing joint venture formed in 2018.
As part of the deal, Scripps Health and UC San Diego Health both purchased interests in Select Medical&#39;s existing critical illness recovery hospital, Select Specialty Hospital &ndash; San Diego, which is licensed as long-term acute care.&nbsp; Select Medical will retain majority ownership and management of the 110-bed facility.&nbsp;
&quot;Since opening Select Specialty Hospital &ndash; San Diego in 2019, there has been a steady increase in the need for specialty care among the region&#39;s aging population facing chronic, critical illness,&quot; said Tom Mullin, executive vice president and chief operating officer of specialty hospitals at Select Medical.&nbsp; &quot;We look forward to partnering with Scripps Health, as well as expanding our relationship with UC San Diego Health, to continue providing world-class post-acute care to Southern California.&quot;&nbsp;&nbsp;
&quot;We are pleased to join with Select Medical in our efforts to meet our patients&#39; needs,&quot; said Richard Neale, corporate executive vice president/chief growth officer for Scripps Health. &quot;It&#39;s part of Scripps&#39; mission&nbsp;to collaborate to deliver the continuum of care that improves the health of our community. Partnering with the others in this venture helps us fulfill that mission.&quot;
&quot;The expansion of this joint venture is an example of how our community of hospitals can collaborate to care for our most vulnerable patients,&quot; said Patty Maysent, chief executive officer, UC San Diego Health. &quot;With the comprehensive resources and clinical expertise of Select Medical and its partners across the region, we will have better transitions of care for all patients recovering from critical illness.&quot;

Select Medical Reports Joint Venture Partnership With Scripps Health, UC San Diego, No Terms Disclosed

Patient engagement leader <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3198888-1&amp;h=2721403297&amp;u=https%3A%2F%2Fcipherhealth.com%2F&amp;a=CipherHealth" target="_blank">CipherHealth</a> announced today that it has forged a new strategic partnership with leading online health insurance marketplace <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3198888-1&amp;h=2468066477&amp;u=https%3A%2F%2Fwww.ehealthinsurance.com%2F&amp;a=eHealth%2C+Inc." target="_blank">eHealth, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) to help hospitals and health systems better educate patients about their Medicare coverage options and the value of Medicare Advantage plans.&nbsp;
<a href="https://mma.prnewswire.com/media/217077/cipherhealth_logo.html" target="_blank"><img alt="CipherHealth Logo (PRNewsFoto/CipherHealth)" src="https://mma.prnewswire.com/media/217077/cipherhealth_logo.jpg" /> </a>
Together, CipherHealth and eHealth enable hospitals and health systems to help their patients navigate care and coverage decisions. Often, this process is so confusing that patients end up in plans that don&#39;t meet their needs, which can impact their care.&nbsp;The combination of eHealth&#39;s omni-channel Medicare navigation and enrollment platform and CipherHealth&#39;s automated outreach solutions support:
<ul>
<li>Patient engagement</li>
<li>Medicare payer strategies</li>
<li>Patient retention</li>
<li>Value-based strategies</li>
<li>Growth and patient acquisition</li>
</ul>
The CipherHealth/eHealth partnership empowers patients to navigate the annual Medicare enrollment process and provides specialized education and outreach for people transitioning into Medicare eligibility.
&quot;CipherHealth&#39;s partnership with eHealth helps us further our mission of empowering purposeful healthcare conversations,&quot; says Alexander Hejnosz, CipherHealth&#39;s Chief Strategy Officer. &quot;In addition to providing solutions for new member onboarding, utilization avoidance, care gap closure, and health maintenance reminders, helping health systems with eHealth&#39;s powerful, intuitive tools makes our engagement platform even more comprehensive. It also addresses a major pain point uncovered by talking to our customers &ndash; namely, the need to close the gap between patients&#39; network of trusted providers and their available Medicare insurance options.&quot;
eHealth delivers capabilities such as a co-branded education and enrollment website, a dedicated call center experience, and customized marketing materials to providers, hospitals, and health systems. The new partnership will add these innovative Medicare navigation resources to CipherHealth&#39;s powerful outreach solutions, giving providers the ability to empower their patients to make the best insurance decisions for their clinical and financial needs.
&quot;The future of health care is consumer-first, built on trust and unbiased transparency. Both CipherHealth and eHealth are passionate about advancing the consumerization of healthcare and empowering patients to make better care and coverage decisions,&quot; says John Connor, eHealth&#39;s Vice President and General Manager of Strategic Partnerships. &quot;We&#39;re excited to collaborate and bring additional Medicare growth and patient retention capabilities to healthcare providers.&quot;

EHTH

CipherHealth Reports Partnership With eHealth To Close Insurance Knowledge Gap Through Automated Outreach

<h1>Nokia and DISH to deploy first 5G standalone core network in the public cloud with AWS</h1>
Press Release
Nokia&nbsp;and&nbsp;DISH to&nbsp;deploy&nbsp;first 5G standalone core network&nbsp;in&nbsp;the&nbsp;public&nbsp;cloud with AWS
<ul>
<li>Nokia builds on relationship with DISH and AWS as DISH deploys the United States&#39; first standalone, 5G cloud network on public cloud

	&nbsp;</li>
</ul>
21 June 2021
Dallas, Texas&nbsp;&ndash;&nbsp;Nokia today&nbsp;said&nbsp;it will deploy its 5G standalone (SA)&nbsp;Core for DISH on Amazon Web Services, Inc. (AWS). While DISH previously announced agreements with both companies, this news marks the world&#39;s first deployment of 5G in the&nbsp;public&nbsp;cloud, supporting DISH&#39;s cloud-native, OpenRAN-based 5G network with high-level scale, performance and security.
Nokia is deploying 5G SA Core on AWS to enable automation required to meet evolving customer needs, allowing DISH to support new enterprise and consumer 5G use cases quickly, securely and across multiple cloud stacks at end customer premises. Nokia 5G SA Core on AWS allows DISH to offer the responsiveness, flexibility and efficiency that is needed to create innovative new services for its customers, while leveraging automation for ongoing operations and unlocking crucial capabilities, such as network slicing.
Nokia is providing voice core, cloud packet core, subscriber data management, device management and&nbsp;<a href="https://www.globenewswire.com/Tracker?data=5zkZGAh99oUfcYUA-NTpCSRZ3KyLsEnzoe2gNNrfJ9_bIF1UtrWykCBifidQirW4T87u5LTWWcns141cjSK5lmKh49aKsdQAe271nbROS34=" target="_blank">NetGuard</a>&nbsp;network security, as well as professional end-to-end security services for DISH. These solutions provide DISH the speed, flexibility and intelligence to deliver new, 5G-era services while cost-effectively managing its network with near zero-touch automation and adherence to Service Level Agreements compliant to DISH Service-Based Architecture (SBA).
Marc Rouanne, Chief Network Officer,&nbsp;DISH, said:&nbsp;&quot;Running the Nokia 5G SA core on AWS will optimize our network operations to launch new software and services rapidly and efficiently, enabling the integration of countless innovative use cases for customers. This collaboration is an important step forward on our mission to deploy the United States&#39; first cloud-native, OpenRAN-based 5G network.&quot;
Dave Brown, Vice President, Amazon EC2,&nbsp;AWS, said:&nbsp;&quot;DISH&#39;s cloud-native 5G
network serves as a prime example of how new carriers can revolutionize wireless
connectivity in the 5G era. DISH is continuing to put innovation first with an eye on customer
experience via this standalone core deployment on AWS with Nokia.&quot;
Raghav Sahgal, President, Cloud and Network Services,&nbsp;Nokia, said:&nbsp;&quot;We are pleased to break new ground in the telecom industry with AWS and DISH leveraging our cloud-native core to bring innovative 5G capabilities to enterprises and consumers. This collaboration places AWS and DISH at the forefront of the industry, delivering key 5G benefits such as agility and scalability to their customers over Nokia&#39;s proven distributed core architecture.&quot;
Resources
<ul>
<li>Webpage:&nbsp;<a href="https://www.nokia.com/networks/portfolio/5g-core/" target="_blank">Nokia 5G Core</a></li>
<li>Webpage:&nbsp;<a href="https://www.nokia.com/networks/solutions/netguard-adaptive-security-operations/" target="_blank">Nokia NetGuard Security</a></li>
<li>Webpage:&nbsp;<a href="https://www.nokia.com/networks/portfolio/device-management-impact/" target="_blank">Nokia Device Management</a>

	&nbsp;</li>
</ul>
About Nokia
We create technology that helps the world act together.
As a trusted partner for critical networks, we are committed to innovation and technology leadership across mobile, fixed and cloud networks. We create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs.
Adhering to the highest standards of integrity and security, we help build the capabilities needed for a more productive, sustainable and inclusive world.
About DISH
DISH Network Corporation is a connectivity company. Since 1980, it has served as a disruptive force, driving innovation and value on behalf of consumers. Through its subsidiaries, the company provides television entertainment and award-winning technology to millions of customers with its satellite DISH TV and streaming SLING TV services. In 2020, the company became a nationwide U.S. wireless carrier through the acquisition of Boost Mobile. DISH continues to innovate in wireless, building the nation&#39;s first virtualized, O-RAN 5G broadband network. DISH Network Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DISH#NASDAQ">DISH</a>) is a Fortune 200 company.
For company information, visit&nbsp;<a href="https://www.globenewswire.com/Tracker?data=_WAtVwTHb0Ku7WJk4IWUbkcr9-gC2BUSUIhgsveBqNj4FtZaaREV6t-3AWaHMC1ErbxeOugk0D2LBK5dU0SBfjV6jH-KJNcf91I1ZbD1nYbL0ME4n4_prExkG6QTOROorsqH05WnOMRM67YOeg9q8zixWXWeBI7wQXHZcDXpKbJ43TYQILFCKCXGVja9fbwRTL8dwparUN0BImJcRM0AhN5ew4tgibX5RNtDMS_BOzQNAlMh81j5TcSr_J_56Y-Yo8vJTAaxpsGLwtIiVFExTj1llZYFnMr7I3pZBu9hCaByZC22BMcEAaN3gBsLE69yT7QUb64LyQUjt5f9b462YQ==" target="_blank">about.dish.com</a>.
Media Inquiries
Nokia
Communications
Phone:&nbsp;+358 10 448 4900
Email:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=zAG1OUsFP8_QdX5ZOHRerwkXOsRNMJlIuV2gR3hSBC50V5xgD6nJ6xDeFBh03UozFQpRFtmta18Vz8maEmD7srlhbMhqnSYmWvs9JxQxL7I=" target="_blank">press.services@nokia.com</a>
<img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMDUxMTU4MyM0MDA5NjkxNzgjMjAwMDA0Mg==" style="height:1px; width:1px" />

DISH

Nokia, DISH To Deploy 'First 5G Standalone Core Network' In The Public Cloud With AWS

Citigroup maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Sell and raises the price target from $46 to $47.

Citigroup Maintains Sell on Aflac, Raises Price Target to $47

Partnership with Curiosity &ndash; Which Recently Entered into an Agreement to be Acquired by Grom Social Enterprises, Inc. &ndash; to Enrich Wildly Popular Collectible Toy Property with Animated Series and Robust Publishing Program
BOCA RATON, FL &ndash; June 21, 2021 &ndash; Grom Social Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grom#NASDAQ">GROM</a>), which recently entered into an agreement to acquire Curiosity Ink Media &ndash; a producer of original multiplatform family entertainment &ndash; today announced that Curiosity has entered into a creative partnership with Cepia LLC to fortify 2021&rsquo;s biggest cat-tastic collectible craze, Cats vs. Pickles, into an original series, along with ancillary publishing extensions. In the silly and colorful world of Cats vs. Pickles, Cats are afraid of Pickles, but Pickles are misunderstood - they just want to be friends. The Cats vs. Pickles brand has established tremendous appeal among global fans with collectible bean-filled toys, wildly popular YouTube animated shorts, and a hyper-casual app game. The announcement was made jointly by Cepia LLC Founder and Chief Executive Officer, James Russell Hornsby, and Russell Hicks, Curiosity Ink Media&rsquo;s Chief Content Officer.&nbsp;
The partnership represents both companies&rsquo; foray into the lucrative and highly profitable worlds of content distribution and publishing - offering new revenue streams for both - unlocking the potential for attendant ancillary businesses including international marketing, licensing and additional consumer products. The alliance will develop Cats vs. Pickles into a recurring series in 11-minute installments, as well as create revenue-generating extensions beginning with published content for consumer purchase. Cats vs. Pickles has no dialogue, and therefore no language or cultural barriers, and its potential for immediate global distribution makes it a unique and compelling programming asset. Simultaneously, Curiosity and Cepia will collaborate to produce a collection of picture, board and activity books expected to hit shelves in 2022.&nbsp;
The alliance will tap into the growing popularity of Cats vs. Pickles, the hit toy property and animated shorts that premiered on YouTube and chronicle the love-hate relationship between cats and pickles. The show&rsquo;s premise is simple: cats hate pickles (true fact) and pickles just want to be loved (research has not yet proven definitively) but the humorous conflict demonstrates that it&rsquo;s silly to be afraid of something just because it may be different. In the tradition of the classic cartoon, Tom &amp; Jerry, Cats vs. Pickles employs clever visual storytelling without the use of dialogue. Misunderstood, the dim-witted pickles &ndash; Joe Pickle, Hank Pickle and Fitzgherkin to name a few - plot complex but doomed-to-fail schemes to get close to cats while in hopeless pursuit of friendship. The colorful cast of cats -including Paw-Purr-Oni, Water-meow-lon and Galacticat - are too self- absorbed to realize the pickle pursuit until it&rsquo;s too late and react to the pickles with frightening alarm. The result is a hilarious feline-vegetable clash.&nbsp;
&ldquo;Cats vs. Pickles has the elements of a franchise hit including a simple premise: loveable characters, endless storytelling possibilities and brand extension opportunities,&rdquo; explains Curiosity&rsquo;s Hicks. &ldquo;Curiosity Ink Media is very excited to partner with the brilliant minds from Cepia to elevate this online sensation from cult hit to global powerhouse at a time when the world could definitely use a laugh, a smile and a message about acceptance.&rdquo;&nbsp;
Cepia&rsquo;s Hornsby added &ldquo;At its core, Cats vs Pickles is a love story that everyone can relate to because, at some point, we&rsquo;ve all been pickles ourselves. We are thrilled to team up with the exceptional storytellers at Curiosity Ink, whose rich biographies in entertainment include cultivating powerhouse franchises like SpongeBob and Dora the Explorer, to expand Cats vs. Pickles into its next nine lives!&rdquo;&nbsp;
About Cepia LLC&nbsp;
Headquartered in St Louis, Mo., Cepia LLC is a privately held company founded by James Russell Hornsby that manufactures toys and games for children of all ages. Cepia&#39;s entertainment property ZhuZhu Pets&reg; was named one of the &ldquo;All-time 100 Greatest Toys&rdquo; by TIME, and received top honor Toy of the Year recognition in five countries, including 2010 &quot;Toy of the Year,&quot; &quot;Most Innovative Toy&quot; and &quot;Best Girls Toy.&quot; By combining kid-friendly technology and innovative creations, the company&#39;s fundamental philosophy is to transform simplistic ideas into magical experiences for kids. Ingenuity, creativity, playfulness and passion are the heart of Cepia.&nbsp;
About Curiosity Ink Media&nbsp;
Curiosity Ink Media is a global media company that develops, acquires, builds, grows and maximizes the short, mid &amp; long-term commercial potential of Kids &amp; Family entertainment properties and associated business opportunities. Driven by a best-in-class leadership team, Curiosity Ink Media&rsquo;s multi-faceted I.P. library is designed to amass ongoing value through strategic stewardship, partnerships and highly targeted market entry.&nbsp;
About Grom Social Enterprises, Inc.
Grom Social Enterprises, Inc. is a growing social media platform and original content provider of entertainment for children under 13 years of age, which provides safe and secure digital environments for kids that can be monitored by their parents or guardians. The Company has several operating subsidiaries, including Grom Social, which delivers its content through mobile and desktop environments (web portal and apps) that entertain children, let them interact with friends, access relevant news, and play proprietary games while teaching them about being good digital citizens. The Company owns and operates Top Draw Animation, which produces award-winning animation content for some of the largest international media companies in the world. Grom also includes Grom Educational Services, which has provided web filtering services for K-12 schools, government and private businesses. For more information, please visit.gromsocial.com.&nbsp;
Contact:
For GROM Social Enterprises/Curiosity Ink Media
Marianne Romano
<a href="mailto:Romanomarianne@me.com">Romanomarianne@me.com</a>
(818) 681-0849
For CEPIA LLC
Laura Frerichs
<a href="mailto:lfrerichs@cepiallc.com">lfrerichs@cepiallc.com</a>

GROM

Curiosity Ink Media Partners with Global Toy Company Cepia to Develop and Produce Entertainment Content for Hit Internet and Toy Franchise,  Cats vs. Pickles®

Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) reported quarterly earnings of $0.17 per share. This is a 41.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $19.00 million which missed the analyst consensus estimate of $30.00 million by 36.67 percent. This is a 30.97 percent decrease over sales of $27.53 million the same period last year.

Earnings

Patriot Transportation Q3 EPS $0.17 Up From $0.12 YoY, Sales $19.00M Miss $30.00M Estimate

<h3>Gainers</h3>

<ul>
	<li>Hertz Global Holdings (NYSE:<a class="ticker" href="/stock/HTZ#NYSE">HTZ</a>) shares increased by 12.25% to $1.8 during Thursday&#39;s regular session. As of 12:31 EST, this security is trading at a volume of 46.4 million shares, making up 137.36% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $256.3 million.</li>
	<li>ALJ Regional Holdings (NASDAQ:<a class="ticker" href="/stock/ALJJ#NASDAQ">ALJJ</a>) shares rose 11.67% to $1.1. Trading volume for ALJ Regional Holdings&#39;s stock is 201.2K as of 12:31 EST. This is 50.39% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.3 million.</li>
	<li>Performance Shipping (NASDAQ:<a class="ticker" href="/stock/PSHG#NASDAQ">PSHG</a>) stock increased by 9.76% to $0.56. Trading volume for Performance Shipping&#39;s stock is 616.6K as of 12:31 EST. This is 67.04% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $28.2 million.</li>
	<li>BEST (NYSE:<a class="ticker" href="/stock/BEST#NYSE">BEST</a>) shares moved upwards by 9.05% to $3.01. BEST&#39;s stock is trading at a volume of 993.6K shares as of 12:31 EST. This is 62.48% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $1.1 billion.</li>
	<li>Art&#39;s-Way Manufacturing (NASDAQ:<a class="ticker" href="/stock/ARTW#NASDAQ">ARTW</a>) stock moved upwards by 8.9% to $2.69. Trading volume for Art&#39;s-Way Manufacturing&#39;s stock is 60.1K as of 12:31 EST. This is 95.14% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.9 million.</li>
	<li>Snap-on (NYSE:<a class="ticker" href="/stock/SNA#NYSE">SNA</a>) stock rose 8.89% to $169.35. The current volume of 1.0 million shares is 280.03% of Snap-on&#39;s average full-day volume over the last 100 days (last updated at 12:31 EST). The market value of their outstanding shares is at $9.2 billion. The company&#39;s, Q3 earnings came out today.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

<ul>
	<li>American Superconductor (NASDAQ:<a class="ticker" href="/stock/AMSC#NASDAQ">AMSC</a>) shares fell 13.4% to $14.81 during Thursday&#39;s regular session. As of 12:31 EST, American Superconductor&#39;s stock is trading at a volume of 1.5 million, which is 534.59% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $335.2 million.</li>
	<li>Pioneer Power Solutions (NASDAQ:<a class="ticker" href="/stock/PPSI#NASDAQ">PPSI</a>) stock decreased by 9.6% to $2.82. Pioneer Power Solutions&#39;s stock is trading at a volume of 377.4K shares as of 12:31 EST. This is 5.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $24.6 million.</li>
	<li>Astrotech (NASDAQ:<a class="ticker" href="/stock/ASTC#NASDAQ">ASTC</a>) stock fell 9.25% to $2.43. As of 12:31 EST, Astrotech&#39;s stock is trading at a volume of 8.3 million, which is 316.71% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.4 million.</li>
	<li>SPAR Group (NASDAQ:<a class="ticker" href="/stock/SGRP#NASDAQ">SGRP</a>) stock decreased by 8.43% to $0.78. SPAR Group&#39;s stock is trading at a volume of 1.1 million shares as of 12:31 EST. This is 409.67% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $16.3 million.</li>
	<li>Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) stock declined by 7.83% to $9.81. Patriot Transportation&#39;s stock is trading at a volume of 879 shares as of 12:31 EST. This is 30.94% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $33.1 million.</li>
	<li>Daseke (NASDAQ:<a class="ticker" href="/stock/DSKE#NASDAQ">DSKE</a>) stock fell 7.69% to $6.25. The current volume of 216.5K shares is 65.57% of Daseke&#39;s average full-day volume over the last 100 days (last updated at 12:31 EST). The company&#39;s market cap stands at $403.8 million.</li>
</ul>

&nbsp;

&nbsp;

Intraday Update

Markets

12 Industrials Stocks Moving In Thursday's Intraday Session

Patriot Transportations Announces A Special Cash Dividend Of $3 Per Shares

<h3>Gainers</h3>

<ul>
	<li>Obalon Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/OBLN#NASDAQ">OBLN</a>) shares jumped 115.9% to $2.31 after declining around 5% on Friday.</li>
	<li>Eastman Kodak Company (NYSE:<a class="ticker" href="/stock/KODK#NYSE">KODK</a>) gained 59.4% to $12.00. There was no wrongdoing involved in the process of Eastman Kodak receiving a $765 million federal loan for its pharmaceuticals foray, the U.S. International Development Finance Corp. has reportedly concluded.</li>
	<li>Oncternal Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ONCT#NASDAQ">ONCT</a>) surged 56.4% to $4.16 after the company disclosed updated interim clinical data from the ongoing Phase 1/2 CIRLL clinical trial.</li>
	<li>Greenland Technologies Holding Corp (NASDAQ:<a class="ticker" href="/stock/GTEC#NASDAQ">GTEC</a>) shares gained 42.9% to $7.93 after the company announced it launched an electric vehicle division.</li>
	<li>Fate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/FATE#NASDAQ">FATE</a>) climbed 34.2% to $81.58 after the company presented data from a patient case study. SVB Leerink maintained Fate Therapeutics with an Outperform and raised the price target from $34 to $58.</li>
	<li>Tonix Pharmaceuticals Holding Corp (NASDAQ:<a class="ticker" href="/stock/TNXP#NASDAQ">TNXP</a>) gained 32.6% to $0.8351 after the company&#39;s Phase 3 study for Fibromyalgia met its primary endpoint.</li>
	<li>Nkarta, Inc. (NASDAQ:<a class="ticker" href="/stock/NKTX#NASDAQ">NKTX</a>) surged 28.5% to $51.03. Nkarta, last month, posted a Q3 loss.</li>
	<li>Hennessy Capital Acquisition Corp. IV. (NASDAQ:<a class="ticker" href="/stock/HCAC#NASDAQ">HCAC</a>) climbed 27.6% to $17.15 after climbing over 10% on Friday.</li>
	<li>Platinum Group Metals Ltd. (NYSE:<a class="ticker" href="/stock/PLG#NYSE">PLG</a>) surged 27% to $3.94.</li>
	<li>Constellation Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="/stock/CNST#NASDAQ">CNST</a>) gained 26.7% to $28.68 as the company issued update of MANIFEST study for CPI-0610 at the ASH meeting.</li>
	<li>CounterPath Corporation (NASDAQ:<a class="ticker" href="/stock/CPAH#NASDAQ">CPAH</a>) surged 25.8% to $3.46. Alianza announced plans to acquire CounterPath for $3.49 per share in cash.</li>
	<li>Luminar Technologies Inc (NASDAQ:<a class="ticker" href="/stock/LAZR#NASDAQ">LAZR</a>) gained 24% to $38.81.</li>
	<li>Tenzing Acquisition Corp. (NASDAQ:<a class="ticker" href="/stock/TZAC#NASDAQ">TZAC</a>) surged 23.3% to $13.44.</li>
	<li>AquaBounty Technologies, Inc. (NASDAQ:<a class="ticker" href="/stock/AQB#NASDAQ">AQB</a>) shares rose 22% to $9.84 after climbing around 28% on Friday.</li>
	<li>Patriot Transportation Holding, Inc. (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) gained 20.6% to $12.00 after announcing a special cash dividend of $3 per share.</li>
	<li>Gamida Cell Ltd. (NASDAQ:<a class="ticker" href="/stock/GMDA#NASDAQ">GMDA</a>) rose 19.3% to $8.31 after the company presented updated and expanded results from Phase 1 study of natural killer cell therapy GDA-201 at the ASH Annual Meeting and Exposition.</li>
	<li>Trine Acquisition Corp. (NASDAQ:<a class="ticker" href="/stock/TRNE#NASDAQ">TRNE</a>) gained 18.8% to $20.65 following a 20% surge on Friday.</li>
	<li>Perion Network Ltd. (NASDAQ:<a class="ticker" href="/stock/PERI#NASDAQ">PERI</a>) jumped 18.5% to $9.16 after the company raised Q4 sales guidance.</li>
	<li>HyreCar Inc. (NASDAQ:<a class="ticker" href="/stock/HYRE#NASDAQ">HYRE</a>) gained 17.7% to $8.44. HyreCar selected Aon as its risk management partner.</li>
	<li>Affimed N.V. (NASDAQ:<a class="ticker" href="/stock/AFMD#NASDAQ">AFMD</a>) jumped 17.6% to $6.61 after the company announced updated AFM13 clinical data presentation at American Society of Hematology Annual Meeting.</li>
	<li>MP Materials Corp. (NYSE:<a class="ticker" href="/stock/MP#NYSE">MP</a>) gained 16.6% to $26.88.</li>
	<li>Second Sight Medical Products, Inc.. (NASDAQ:<a class="ticker" href="/stock/EYES#NASDAQ">EYES</a>) climbed 15.3% to $1.6140.</li>
	<li>Seacor Holdings Inc. (NYSE:<a class="ticker" href="/stock/CKH#NYSE">CKH</a>) gained 15.3% to $41.83 after the company announced it would be acquired by a private equity firm American Industrial Partners for $41.50per share in cash.</li>
	<li>Syros Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="/stock/SYRS#NASDAQ">SYRS</a>) gained 14.3% to $8.87 after the company acquired clinical-stage drug candidate for acute promyelocytic leukemia. Syros also presented new compelling data from Phase 2 clinical trial of SY-1425 at ASH 2020 and announced plans to initiate registration-enabling trial in MDS and randomized Phase 2 trial in AML.</li>
	<li>Veritone, Inc. (NASDAQ:<a class="ticker" href="/stock/VERI#NASDAQ">VERI</a>) jumped 14% to $30.98. Veritone, last week, reported a 3 million share common stock offering at $18.50 per share.</li>
	<li>Alpha and Omega Semiconductor Limited (NASDAQ:<a class="ticker" href="/stock/AOSL#NASDAQ">AOSL</a>) gained 13.6% to $28.14.</li>
	<li>Foley Trasimene Acquisition Corp. II (NYSE:<a class="ticker" href="/stock/BFT#NYSE">BFT</a>) shares rose 13.1% to $12.02. Foley Trasimene Acquisition Corp. II and Paysafe Group Holdings Limited entered into a definitive agreement and plan of merger.</li>
	<li>Anworth Mortgage Asset Corporation (NYSE:<a class="ticker" href="/stock/ANH#NYSE">ANH</a>) gained 10.2% to $2.5891. Ready Capital and Anworth Mortgage Asset reported a merger transaction.</li>
	<li>Kubient, Inc. (NASDAQ:<a class="ticker" href="/stock/KBNT#NASDAQ">KBNT</a>) rose 10.1% to $6.64 after surging 23% on Friday.</li>
	<li>Micro Focus International plc (NYSE:<a class="ticker" href="/stock/MFGP#NYSE">MFGP</a>) surged 9.7% to $6.39. Micro Focus climbed last week following Amazon AWS post highlighting the company as a partner for AWS mainframe migration competency.</li>
	<li>GSX Techedu Inc. (NYSE:<a class="ticker" href="/stock/GSX#NYSE">GSX</a>) rose 9% to $66.20 after the company reported private placement financing of $870 million.</li>
	<li>Atara Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ATRA#NASDAQ">ATRA</a>) rose 7.7% to $26.48. Bayer and Atara Biotherapeutics reported a strategic collaboration for mesothelin-targeted CAR T-cell therapies for solid tumors.</li>
	<li>Safe-T Group Ltd (NASDAQ:<a class="ticker" href="/stock/SFET#NASDAQ">SFET</a>) shares rose 6.6% to $1.30 after surging 16% on Friday. Safe-T Group, last week, reported a partnership with Systematika to distribute proprietary cybersecurity solutions in Italy.</li>
	<li>Aurora Mobile Limited (NASDAQ:<a class="ticker" href="/stock/JG#NASDAQ">JG</a>) rose 6.2% to $3.45 after the company disclosed a partnership with Niu Technologies to create optimal smart mobility experience for users.</li>
</ul>

&nbsp;

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>scPharmaceuticals Inc. (NASDAQ:<a class="ticker" href="/stock/SCPH#NASDAQ">SCPH</a>) shares dipped 32.8% to $5.87 after the company received Complete Response Letter from the FDA for FUROSCIX. The company said, &#39;In the CRL, the FDA cited their need to conduct pre-approval inspections at two of the company&#39;s third-party manufacturing facilities that could not be conducted due to travel restrictions.&#39;</li>
	<li>Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="/stock/APTO#NASDAQ">APTO</a>) dipped 30% to $4.2850 after issued highlights from the ASH and corporate update event.</li>
	<li>Globus Maritime Limited (NASDAQ:<a class="ticker" href="/stock/GLBS#NASDAQ">GLBS</a>) fell 28.9% to $7.42 after the company reported a drop in Q3 earnings and sales. Globus Maritime also priced its 1.41 million unit public offering at $8.50 per share.</li>
	<li>Lyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/LYRA#NASDAQ">LYRA</a>) fell 20.9% to $9.88 after the company said its topline results for LANTERN phase 2 in a randomized controlled study of its LYR-210 for the treatment of Chronic Rhinosinusitis did not reach its primary endpoint.</li>
	<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="/stock/MBIO#NASDAQ">MBIO</a>) dipped 18.8% to $3.12. Mustang Bio highlighted presentation of interim Phase 1/2 data for MB-106 in patients with relapsed or refractory B-cell non-hodgkin lymphoma at the ASH Meeting.</li>
	<li>Natuzzi S.p.A. (NYSE:<a class="ticker" href="/stock/NTZ#NYSE">NTZ</a>) fell 18% to $11.82 after climbing over 21% on Friday.</li>
	<li>Sigilon Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/SGTX#NASDAQ">SGTX</a>) dropped 16.6% to $29.01. Sigilon Therapeutics shares surged 93% on Friday after the company priced its IPO at $18 per share.</li>
	<li>LightInTheBox Holding Co., Ltd. (NYSE:<a class="ticker" href="/stock/LITB#NYSE">LITB</a>) fell 16.1% to $2.81 after reporting Q3 results.</li>
	<li>Auris Medical Holding Ltd. (NASDAQ:<a class="ticker" href="/stock/EARS#NASDAQ">EARS</a>) tumbled 15.6% to $2.7846.</li>
	<li>Sotherly Hotels Inc. (NASDAQ:<a class="ticker" href="/stock/SOHO#NASDAQ">SOHO</a>) fell 15.1% to $2.675 after climbing over 32% on Friday.</li>
	<li>Sundial Growers Inc. (NASDAQ:<a class="ticker" href="/stock/SNDL#NASDAQ">SNDL</a>) fell 15% to $0.5640. Sundial Growers shares dipped 14% on Friday after the company announced it filed a &quot;universal&quot; shelf registration statement allowing for the offer and sale of various securities in an amount of up to US$200 million.</li>
	<li>China HGS Real Estate Inc. (NASDAQ:<a class="ticker" href="/stock/HGSH#NASDAQ">HGSH</a>) fell 13.9% to $2.2227 after jumping over 46% on Friday.</li>
	<li>China Automotive Systems, Inc. (NASDAQ:<a class="ticker" href="/stock/CAAS#NASDAQ">CAAS</a>) dipped 12.8% to $6.82. China Automotive announced hearing on February 5, 2021 on proposal to settle stockholder derivative lawsuit.</li>
	<li>Allogene Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ALLO#NASDAQ">ALLO</a>) dropped 11.8% to $29.65 as the company presented preclinical findings supporting ALLO-605 at the ASH 2020.</li>
	<li>Lordstown Motors Corp. (NASDAQ:<a class="ticker" href="/stock/RIDE#NASDAQ">RIDE</a>) shares fell 11.7% to $20.72.</li>
	<li>HEXO Corp. (NYSE:<a class="ticker" href="/stock/HEXO#NYSE">HEXO</a>) fell 10.3% to $0.9693 after the company reported downward revision to its proposed share consolidation ratio.</li>
	<li>Top Ships Inc. (NASDAQ:<a class="ticker" href="/stock/TOPS#NASDAQ">TOPS</a>) shares fell 10.3% to $1.48 after climbing over 38% on Friday.</li>
	<li>India Globalization Capital, Inc. (NYSE:<a class="ticker" href="/stock/IGC#NYSE">IGC</a>) fell 9.3% to $1.8055.</li>
	<li>Nano Dimension Ltd. (NASDAQ:<a class="ticker" href="/stock/NNDM#NASDAQ">NNDM</a>) shares fell 8.6% to $6.80 after the company priced its $180 million registered direct offering.</li>
	<li>NanoVibronix, Inc. (NASDAQ:<a class="ticker" href="/stock/NAOV#NASDAQ">NAOV</a>) fell 6.9% to $1.0150.</li>
</ul>

Penny Stocks

Small Cap

54 Stocks Moving In Monday's Mid-Day Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Greenland Technologies (NASDAQ:<a class="ticker" href="/stock/GTEC#NASDAQ">GTEC</a>) shares increased by 82.88% to $10.15 during Monday&#39;s regular session. As of 12:33 EST, Greenland Technologies&#39;s stock is trading at a volume of 45.9 million, which is 1290.51% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $103.0 million.</li>
	<li>Eastman Kodak (NYSE:<a class="ticker" href="/stock/KODK#NYSE">KODK</a>) shares rose 61.48% to $12.16. As of 12:33 EST, Eastman Kodak&#39;s stock is trading at a volume of 103.8 million, which is 661.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $938.3 million.</li>
	<li>EHang Holdings (NASDAQ:<a class="ticker" href="/stock/EH#NASDAQ">EH</a>) stock rose 29.88% to $17.47. Trading volume for this security as of 12:33 EST is 1.8 million, which is 618.15% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $956.1 million. The company&#39;s, Q3 earnings came out 2 days ago.</li>
	<li>ENGlobal (NASDAQ:<a class="ticker" href="/stock/ENG#NASDAQ">ENG</a>) shares moved upwards by 23.63% to $2.24. As of 12:33 EST, this security is trading at a volume of 2.8 million shares, making up 128.22% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $61.6 million.</li>
	<li>Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) shares moved upwards by 19.31% to $11.55. Patriot Transportation&#39;s stock is trading at a volume of 93.5K shares as of 12:33 EST. This is 3397.97% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $39.0 million. As per the press release, Q4 earnings came out 3 days ago.</li>
	<li>CBAK Energy Technology (NASDAQ:<a class="ticker" href="/stock/CBAT#NASDAQ">CBAT</a>) stock rose 16.58% to $6.96. As of 12:33 EST, this security is trading at a volume of 5.0 million shares, making up 34.77% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $462.6 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Globus Maritime (NASDAQ:<a class="ticker" href="/stock/GLBS#NASDAQ">GLBS</a>) stock declined by 29.05% to $7.4 during Monday&#39;s regular session. Trading volume for this security as of 12:33 EST is 916.7K, which is 11.94% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.0 million. As per the press release, Q3 earnings came out yesterday.</li>
	<li>Seanergy Maritime Hldgs (NASDAQ:<a class="ticker" href="/stock/SHIP#NASDAQ">SHIP</a>) shares declined by 12.49% to $0.54. Trading volume for this security as of 12:33 EST is 14.8 million, which is 242.05% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $37.0 million.</li>
	<li>Euroseas (NASDAQ:<a class="ticker" href="/stock/ESEA#NASDAQ">ESEA</a>) stock declined by 12.08% to $4.66. The current volume of 125.3K shares is 79.31% of Euroseas&#39;s average full-day volume over the last 100 days (last updated at 12:33 EST). The market value of their outstanding shares is at $26.0 million.</li>
	<li>Castor Maritime (NASDAQ:<a class="ticker" href="/stock/CTRM#NASDAQ">CTRM</a>) stock declined by 10.66% to $0.18. Trading volume for Castor Maritime&#39;s stock is 15.9 million as of 12:33 EST. This is 154.06% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.4 million.</li>
	<li>DLH Hldgs (NASDAQ:<a class="ticker" href="/stock/DLHC#NASDAQ">DLHC</a>) shares declined by 10.27% to $9.79. Trading volume for DLH Hldgs&#39;s stock is 46.8K as of 12:33 EST. This is 136.95% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $120.9 million. As per the news, the Q4 earnings report came out today.</li>
	<li>Nesco Holdings (NYSE:<a class="ticker" href="/stock/NSCO#NYSE">NSCO</a>) shares decreased by 10.06% to $6.02. The current volume of 353.3K shares is 72.29% of Nesco Holdings&#39;s average full-day volume over the last 100 days (last updated at 12:33 EST). The market value of their outstanding shares is at $295.0 million.</li>
</ul>

&nbsp;

&nbsp;

12 Industrials Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>

<ul>
	<li>Obalon Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/OBLN#NASDAQ">OBLN</a>) shares climbed 115% to close at $2.30 on Monday after declining around 5% on Friday.</li>
	<li>Eastman Kodak Company (NYSE:<a class="ticker" href="/stock/KODK#NYSE">KODK</a>) surged 59.9% to close at $12.04. There was no wrongdoing involved in the process of Eastman Kodak receiving a $765 million federal loan for its pharmaceuticals foray, the U.S. International Development Finance Corp. has reportedly concluded.</li>
	<li>Gamida Cell Ltd. (NASDAQ:<a class="ticker" href="/stock/GMDA#NASDAQ">GMDA</a>) jumped 56.2% to close at $10.89 after the company presented updated and expanded results from Phase 1 study of natural killer cell therapy GDA-201 at the ASH Annual Meeting and Exposition.</li>
	<li>Oncternal Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ONCT#NASDAQ">ONCT</a>) gained 49.6% to close at $3.98 after the company disclosed updated interim clinical data from the ongoing Phase 1/2 CIRLL clinical trial.</li>
	<li>Greenland Technologies Holding Corp (NASDAQ:<a class="ticker" href="/stock/GTEC#NASDAQ">GTEC</a>) shares rose 49.4% to close at $8.29 after the company announced it launched an electric vehicle division.</li>
	<li>Kubient, Inc. (NASDAQ:<a class="ticker" href="/stock/KBNT#NASDAQ">KBNT</a>) jumped 43.6% to close at $8.66 after surging 23% on Friday.</li>
	<li>HighPeak Energy, Inc. (NASDAQ:<a class="ticker" href="/stock/HPK#NASDAQ">HPK</a>) gained 39.6% to close at $6.98.</li>
	<li>Fate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/FATE#NASDAQ">FATE</a>) jumped 37.8% to close at $83.77 after the company presented data from a patient case study. SVB Leerink maintained Fate Therapeutics with an Outperform and raised the price target from $34 to $58.</li>
	<li>Hennessy Capital Acquisition Corp. IV. (NASDAQ:<a class="ticker" href="/stock/HCAC#NASDAQ">HCAC</a>) gained 35.3% to close at $18.20 after climbing over 10% on Friday.</li>
	<li>EHang Holdings Limited (NASDAQ:<a class="ticker" href="/stock/EH#NASDAQ">EH</a>) surged 34.9% to close at $18.14. EHang Holdings, last week, reported better-than-expected Q3 sales.</li>
	<li>Constellation Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="/stock/CNST#NASDAQ">CNST</a>) surged 34.1% to close at $30.35 as the company issued update of MANIFEST study for CPI-0610 at the ASH meeting.</li>
	<li>CIIG Merger Corp. (NASDAQ:<a class="ticker" href="/stock/CIIC#NASDAQ">CIIC</a>) gained 33% to close at $36.23 after climbing 26% on Friday.</li>
	<li>Luminar Technologies Inc (NASDAQ:<a class="ticker" href="/stock/LAZR#NASDAQ">LAZR</a>) rose 30.2% to close at $40.88.</li>
	<li>Platinum Group Metals Ltd. (NYSE:<a class="ticker" href="/stock/PLG#NYSE">PLG</a>) gained 29.4% to close at $4.01.</li>
	<li>Chimerix, Inc. (NASDAQ:<a class="ticker" href="/stock/CMRX#NASDAQ">CMRX</a>) shares jumped 25.4% to close at $4.54 as the company reported the FDA acceptance of New drug application for brincidofovir as a medical countermeasure for smallpox.</li>
	<li>CounterPath Corporation (NASDAQ:<a class="ticker" href="/stock/CPAH#NASDAQ">CPAH</a>) gained 25.1% to close at $3.44. Alianza announced plans to acquire CounterPath for $3.49 per share in cash.</li>
	<li>Velodyne Lidar, Inc. (NASDAQ:<a class="ticker" href="/stock/VLDR#NASDAQ">VLDR</a>) surged 24.4% to close at $18.81.</li>
	<li>Sino-Global Shipping America, Ltd. (NASDAQ:<a class="ticker" href="/stock/SINO#NASDAQ">SINO</a>) surged 22.8% to close at $3.50.</li>
	<li>ADDvantage Technologies Group, Inc. (NASDAQ:<a class="ticker" href="/stock/AEY#NASDAQ">AEY</a>) jumped 22.6% to close at $4.07.</li>
	<li>Nkarta, Inc. (NASDAQ:<a class="ticker" href="/stock/NKTX#NASDAQ">NKTX</a>) gained 21.7% to close at $48.31. Nkarta, last month, posted a Q3 loss.</li>
	<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="/stock/PLTR#NYSE">PLTR</a>) rose 21.3% to close at $28.94 following a Bloomberg report of the company landing a three-year, $44-million contract with the U.S. Food and Drug Administration.</li>
	<li>Affimed N.V. (NASDAQ:<a class="ticker" href="/stock/AFMD#NASDAQ">AFMD</a>) climbed 20.5% to close at $6.77 after the company announced updated AFM13 clinical data presentation at American Society of Hematology Annual Meeting.</li>
	<li>MP Materials Corp. (NYSE:<a class="ticker" href="/stock/MP#NYSE">MP</a>) surged 20% to close at $27.68.</li>
	<li>Trine Acquisition Corp. (NASDAQ:<a class="ticker" href="/stock/TRNE#NASDAQ">TRNE</a>) rose 19.5% to close at $20.75 following a 20% surge on Friday.</li>
	<li>AquaBounty Technologies, Inc. (NASDAQ:<a class="ticker" href="/stock/AQB#NASDAQ">AQB</a>) shares gained 19.4% to close at $9.62 after climbing around 28% on Friday.</li>
	<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="/stock/CVM#NYSE">CVM</a>) gained 18.5% to close at $14.24 after the company issued an update on Phase 3 cancer trial results.</li>
	<li>BioCryst Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="/stock/BCRX#NASDAQ">BCRX</a>) jumped 18.4% to close at $7.22 after the company disclosed $325 million of funding from Royalty Pharma and Athyrium Capital Management. HC Wainwright &amp; Co. maintained BioCryst Pharmaceuticals with a Buy and raised the price target from $13 to $14.</li>
	<li>Contura Energy, Inc. (NYSE:<a class="ticker" href="/stock/CTRA#NYSE">CTRA</a>) rose 18.3% to close at $8.99.</li>
	<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="/stock/SONN#NASDAQ">SONN</a>) gained 18.3% to close at $2.98. Sonnet BioTherapeutics, last week, announced completion of successful non-human primate study of SON-1010.</li>
	<li>GeoVax Labs, Inc. (NASDAQ:<a class="ticker" href="/stock/GOVX#NASDAQ">GOVX</a>) rose 18.2% to close at $3.24.</li>
	<li>Social Capital Hedosophia Holdings Corp. II (NYSE:<a class="ticker" href="/stock/IPOB#NYSE">IPOB</a>) gained 18.1% to close at $25.59.</li>
	<li>Virgin Galactic Holdings, Inc. (NYSE:<a class="ticker" href="/stock/SPCE#NYSE">SPCE</a>) jumped 17.6% to close at $33.80.</li>
	<li>Silverback Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/SBTX#NASDAQ">SBTX</a>) jumped 17.6% to close at $29.40. Silverback Therapeutics gained 19% on Friday as the company priced 11.5 million share IPO at $21 per share.</li>
	<li>Syros Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="/stock/SYRS#NASDAQ">SYRS</a>) surged 17.3% to close at $9.10 after the company acquired clinical-stage drug candidate for acute promyelocytic leukemia. Syros also presented new compelling data from Phase 2 clinical trial of SY-1425 at ASH 2020 and announced plans to initiate registration-enabling trial in MDS and randomized Phase 2 trial in AML.</li>
	<li>Ampco-Pittsburgh Corporation (NYSE:<a class="ticker" href="/stock/AP#NYSE">AP</a>) jumped 16.9% to close at $5.46.</li>
	<li>Perion Network Ltd. (NASDAQ:<a class="ticker" href="/stock/PERI#NASDAQ">PERI</a>) gained 16.7% to close at $9.02 after the company raised Q4 sales guidance.</li>
	<li>IGM Biosciences, Inc. (NASDAQ:<a class="ticker" href="/stock/IGMS#NASDAQ">IGMS</a>) surged 16.6% to close at $72.92 after the company presented first clinical data from IGM-2323 in non-Hodgkin&rsquo;s lymphoma at the 2020 ASH Annual Meeting. IGM Biosciences reported a $150 million common stock offering after the closing bell.</li>
	<li>HighPoint Resources Corporation (NYSE:<a class="ticker" href="/stock/HPR#NYSE">HPR</a>) gained 16.4% to close at $12.77.</li>
	<li>Mercurity Fintech Holding Inc. (NASDAQ:<a class="ticker" href="/stock/MFH#NASDAQ">MFH</a>) surged 16.2% to close at $3.22.</li>
	<li>Cellectar Biosciences, Inc. (NASDAQ:<a class="ticker" href="/stock/CLRB#NASDAQ">CLRB</a>) gained 15.2% to close at $2.35.</li>
	<li>Safe-T Group Ltd (NASDAQ:<a class="ticker" href="/stock/SFET#NASDAQ">SFET</a>) shares jumped 14.8% to close at $1.40 after surging 16% on Friday. Safe-T Group, last week, reported a partnership with Systematika to distribute proprietary cybersecurity solutions in Italy.</li>
	<li>Seacor Holdings Inc. (NYSE:<a class="ticker" href="/stock/CKH#NYSE">CKH</a>) surged 14.7% to close at $41.64 after the company announced it would be acquired by a private equity firm American Industrial Partners for $41.50per share in cash.</li>
	<li>Patriot Transportation Holding, Inc. (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) climbed 14.6% to close at $11.40 after announcing a special cash dividend of $3 per share.</li>
	<li>Alpha and Omega Semiconductor Limited (NASDAQ:<a class="ticker" href="/stock/AOSL#NASDAQ">AOSL</a>) surged 14.5% to close at $28.36.</li>
	<li>Foley Trasimene Acquisition Corp. II (NYSE:<a class="ticker" href="/stock/BFT#NYSE">BFT</a>) shares gained 12.5% to close at $11.95. Foley Trasimene Acquisition Corp. II and Paysafe Group Holdings Limited entered into a definitive agreement and plan of merger.</li>
	<li>Micro Focus International plc (NYSE:<a class="ticker" href="/stock/MFGP#NYSE">MFGP</a>) gained 12.2% to close at $6.54. Micro Focus climbed last week following Amazon AWS post highlighting the company as a partner for AWS mainframe migration competency.</li>
	<li>Tonix Pharmaceuticals Holding Corp (NASDAQ:<a class="ticker" href="/stock/TNXP#NASDAQ">TNXP</a>) rose 11.1% to close at $0.70 after the company&#39;s Phase 3 study for Fibromyalgia met its primary endpoint.</li>
	<li>Veritone, Inc. (NASDAQ:<a class="ticker" href="/stock/VERI#NASDAQ">VERI</a>) gained 10.5% to close at $30.01. Veritone, last week, reported a 3 million share common stock offering at $18.50 per share.</li>
	<li>HyreCar Inc. (NASDAQ:<a class="ticker" href="/stock/HYRE#NASDAQ">HYRE</a>) rose 8.8% to close at $7.80. HyreCar selected Aon as its risk management partner.</li>
	<li>Second Sight Medical Products, Inc.. (NASDAQ:<a class="ticker" href="/stock/EYES#NASDAQ">EYES</a>) gained 8.6% to close at $1.52.</li>
	<li>Anworth Mortgage Asset Corporation (NYSE:<a class="ticker" href="/stock/ANH#NYSE">ANH</a>) rose 8.1% to close at $2.54. Ready Capital and Anworth Mortgage Asset reported a merger transaction.</li>
	<li>Aurora Mobile Limited (NASDAQ:<a class="ticker" href="/stock/JG#NASDAQ">JG</a>) gained 7.1% to close at $3.48 after the company disclosed a partnership with Niu Technologies to create optimal smart mobility experience for users.</li>
	<li>Atara Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ATRA#NASDAQ">ATRA</a>) gained 6.8% to close at $26.27. Bayer and Atara Biotherapeutics reported a strategic collaboration for mesothelin-targeted CAR T-cell therapies for solid tumors.</li>
	<li>GSX Techedu Inc. (NYSE:<a class="ticker" href="/stock/GSX#NYSE">GSX</a>) gained 6.6% to close at $64.72 after the company reported private placement financing of $870 million.</li>
</ul>

&nbsp;

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>scPharmaceuticals Inc. (NASDAQ:<a class="ticker" href="/stock/SCPH#NASDAQ">SCPH</a>) shares tumbled 35.6% to close at $5.62 on Monday after the company received Complete Response Letter from the FDA for FUROSCIX. The company said, &#39;In the CRL, the FDA cited their need to conduct pre-approval inspections at two of the company&#39;s third-party manufacturing facilities that could not be conducted due to travel restrictions.&#39;</li>
	<li>Globus Maritime Limited (NASDAQ:<a class="ticker" href="/stock/GLBS#NASDAQ">GLBS</a>) declined 29.1% to close at $7.40 after the company reported a drop in Q3 earnings and sales. Globus Maritime also priced its 1.41 million unit public offering at $8.50 per share.</li>
	<li>Lyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/LYRA#NASDAQ">LYRA</a>) dropped 25.3% to close at $9.32 after the company said its topline results for LANTERN phase 2 in a randomized controlled study of its LYR-210 for the treatment of Chronic Rhinosinusitis did not reach its primary endpoint.</li>
	<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="/stock/INTZ#NASDAQ">INTZ</a>) declined 21.9% to close at $13.91.</li>
	<li>Sundial Growers Inc. (NASDAQ:<a class="ticker" href="/stock/SNDL#NASDAQ">SNDL</a>) fell 21% to close at $0.5240. Sundial Growers shares dipped 14% on Friday after the company announced it filed a &quot;universal&quot; shelf registration statement allowing for the offer and sale of various securities in an amount of up to US$200 million.</li>
	<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="/stock/MBIO#NASDAQ">MBIO</a>) fell 19% to close at $3.11. Mustang Bio highlighted presentation of interim Phase 1/2 data for MB-106 in patients with relapsed or refractory B-cell non-hodgkin lymphoma at the ASH Meeting.</li>
	<li>LightInTheBox Holding Co., Ltd. (NYSE:<a class="ticker" href="/stock/LITB#NYSE">LITB</a>) fell 18.2% to close at $2.74 after reporting Q3 results.</li>
	<li>Natuzzi S.p.A. (NYSE:<a class="ticker" href="/stock/NTZ#NYSE">NTZ</a>) fell 18.2% to close at $11.79 after climbing over 21% on Friday.</li>
	<li>Sumo Logic, Inc. (NASDAQ:<a class="ticker" href="/stock/SUMO#NASDAQ">SUMO</a>) dipped 18.1% to close at $24.66 after the company disclosed Q3 results.</li>
	<li>Spruce Biosciences, Inc. (NASDAQ:<a class="ticker" href="/stock/SPRB#NASDAQ">SPRB</a>) fell 17.3% to close at $24.30.</li>
	<li>Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="/stock/APTO#NASDAQ">APTO</a>) fell 16.8% to close at $5.09 after issued highlights from the ASH and corporate update event.</li>
	<li>Auris Medical Holding Ltd. (NASDAQ:<a class="ticker" href="/stock/EARS#NASDAQ">EARS</a>) fell 16.4% to close at $2.76.</li>
	<li>MDJM Ltd. (NASDAQ:<a class="ticker" href="/stock/MDJH#NASDAQ">MDJH</a>) fell 15.9% to close at $3.43.</li>
	<li>Lordstown Motors Corp. (NASDAQ:<a class="ticker" href="/stock/RIDE#NASDAQ">RIDE</a>) shares fell 14.4% to close at $20.08.</li>
	<li>Nova LifeStyle, Inc. (NASDAQ:<a class="ticker" href="/stock/NVFY#NASDAQ">NVFY</a>) dropped 13.7% to close at $2.08.</li>
	<li>Allogene Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/ALLO#NASDAQ">ALLO</a>) fell 13.6% to close at $29.06 as the company presented preclinical findings supporting ALLO-605 at the ASH 2020.</li>
	<li>Sotherly Hotels Inc. (NASDAQ:<a class="ticker" href="/stock/SOHO#NASDAQ">SOHO</a>) fell 13.3% to close at $2.73 after climbing over 32% on Friday.</li>
	<li>China HGS Real Estate Inc. (NASDAQ:<a class="ticker" href="/stock/HGSH#NASDAQ">HGSH</a>) fell 12.4% to close at $2.26 after jumping over 46% on Friday.</li>
	<li>Sigilon Therapeutics, Inc. (NASDAQ:<a class="ticker" href="/stock/SGTX#NASDAQ">SGTX</a>) dropped 12% to close at $30.60. Sigilon Therapeutics shares surged 93% on Friday after the company priced its IPO at $18 per share.</li>
	<li>India Globalization Capital, Inc. (NYSE:<a class="ticker" href="/stock/IGC#NYSE">IGC</a>) fell 10.6% to close at $1.78.</li>
	<li>Nano Dimension Ltd. (NASDAQ:<a class="ticker" href="/stock/NNDM#NASDAQ">NNDM</a>) shares dropped 10.4% to close at $6.67 after the company priced its $180 million registered direct offering.</li>
	<li>Top Ships Inc. (NASDAQ:<a class="ticker" href="/stock/TOPS#NASDAQ">TOPS</a>) shares fell 9.7% to close at $1.49 after climbing over 38% on Friday.</li>
	<li>NanoVibronix, Inc. (NASDAQ:<a class="ticker" href="/stock/NAOV#NASDAQ">NAOV</a>) fell 8.3% to close at $1.00.</li>
	<li>HEXO Corp. (NYSE:<a class="ticker" href="/stock/HEXO#NYSE">HEXO</a>) fell 6.5% to close at $1.01 after the company reported downward revision to its proposed share consolidation ratio.</li>
</ul>

78 Biggest Movers From Yesterday

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) shares increased by 12.5% to $13.5 during Monday&#39;s pre-market session. The market value of their outstanding shares is at $45.5 million.</li>
	<li>Broadwind (NASDAQ:<a class="ticker" href="/stock/BWEN#NASDAQ">BWEN</a>) shares moved upwards by 5.94% to $4.1. The company&#39;s market cap stands at $69.4 million.</li>
	<li>Golden Ocean Group (NASDAQ:<a class="ticker" href="/stock/GOGL#NASDAQ">GOGL</a>) shares moved upwards by 5.84% to $4.71. The company&#39;s market cap stands at $675.0 million.</li>
	<li>AZEK Co (NYSE:<a class="ticker" href="/stock/AZEK#NYSE">AZEK</a>) shares rose 5.81% to $37.1. The company&#39;s market cap stands at $5.7 billion.</li>
	<li>Grindrod Shipping Hldgs (NASDAQ:<a class="ticker" href="/stock/GRIN#NASDAQ">GRIN</a>) shares increased by 5.47% to $3.66. The company&#39;s market cap stands at $69.5 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Virgin Galactic Hldgs (NYSE:<a class="ticker" href="/stock/SPCE#NYSE">SPCE</a>) stock fell 15.58% to $27.05 during Monday&#39;s pre-market session. The market value of their outstanding shares is at $6.3 billion.</li>
	<li>TOP Ships (NASDAQ:<a class="ticker" href="/stock/TOPS#NASDAQ">TOPS</a>) shares declined by 4.19% to $1.26. The company&#39;s market cap stands at $50.1 million.</li>
	<li>Hydrofarm Holdings Group (NASDAQ:<a class="ticker" href="/stock/HYFM#NASDAQ">HYFM</a>) stock declined by 3.73% to $46.5.</li>
	<li>Antelope Enterprise (NASDAQ:<a class="ticker" href="/stock/AEHL#NASDAQ">AEHL</a>) stock fell 3.48% to $2.22.</li>
	<li>Professional Diversity (NASDAQ:<a class="ticker" href="/stock/IPDN#NASDAQ">IPDN</a>) stock fell 3.34% to $1.45. The market value of their outstanding shares is at $18.5 million.</li>
	<li>Castor Maritime (NASDAQ:<a class="ticker" href="/stock/CTRM#NASDAQ">CTRM</a>) stock fell 2.3% to $0.16. The market value of their outstanding shares is at $21.2 million.</li>
</ul>

&nbsp;

&nbsp;

11 Industrials Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>

<ul>
	<li>Neovasc Inc. (NASDAQ:<a class="ticker" href="/stock/NVCN#NASDAQ">NVCN</a>) rose 109% to $1.63 in pre-market trading. Neovasc, on Tuesday, said it has received written notification from the Nasdaq that the company is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq. The company has been given until June 14, 2021 to regain compliance. The company also said it has completed the first three Neovasc Reducer&trade; implants in France..</li>
	<li>Sio Gene Therapies, Inc. (NASDAQ:<a class="ticker" href="/stock/SIOX#NASDAQ">SIOX</a>) rose 38.7% to $3.94 in pre-market trading after the company disclosed &quot;positive&quot; six-month follow-up data from a low-dose cohort of Phase 1/2 trial of AXO-AAV-GM1.</li>
	<li>Bridgetown Holdings Limited (NASDAQ:<a class="ticker" href="/stock/BTWN#NASDAQ">BTWN</a>) rose 30% to $14.50 in pre-market trading. Bridgetown Holdings shares climbed over 22% on Tuesday on reports the SPAC is considering a merger with PT Tokopedia.</li>
	<li>New Providence Acquisition Corp. (NASDAQ:<a class="ticker" href="/stock/NPA#NASDAQ">NPA</a>) shares rose 26% to $13.00 in pre-market trading.</li>
	<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="/stock/BLRX#NASDAQ">BLRX</a>) rose 21.8% to $4.41 in pre-market trading after the company reported final results from Phase 2a COMBAT/KEYNOTE-202 triple combination study of motixafortide in second line metastatic pancreatic cancer.</li>
	<li>Tilray, Inc. (NASDAQ:<a class="ticker" href="/stock/TLRY#NASDAQ">TLRY</a>) rose 21% to $9.52 in pre-market trading on reports the company is in advanced merger talks with Aphria.</li>
	<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="/stock/URGN#NASDAQ">URGN</a>) rose 19.3% to $22.00 in pre-market trading.</li>
	<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="/stock/LQDA#NASDAQ">LQDA</a>) shares rose 18.2% to $3.45 in pre-market trading. Liquidia, on Monday, reported a CEO transition.</li>
	<li>Code Chain New Continent Limited (NASDAQ:<a class="ticker" href="/stock/CCNC#NASDAQ">CCNC</a>) rose 17.3% to $2.24 in pre-market trading after climbing over 22% on Tuesday.</li>
	<li>MIND Technology, Inc. (NASDAQ:<a class="ticker" href="/stock/MIND#NASDAQ">MIND</a>) rose 15.8% to $2.05 in pre-market trading after declining 28% on Tuesday. MIND Technology, earlier during the month, posted a Q3 loss.</li>
	<li>Drive Shack Inc. (NYSE:<a class="ticker" href="/stock/DS#NYSE">DS</a>) rose 13.1% to $2.77 in pre-market trading. Drive Shack is scheduled to reopen its Orlando venue on December 18th.</li>
	<li>Aphria Inc. (NASDAQ:<a class="ticker" href="/stock/APHA#NASDAQ">APHA</a>) rose 12.3% to $9.12 in pre-market trading on reports the company is in advanced merger talks with Tilray.</li>
	<li>Hancock Jaffe Laboratories Inc (NASDAQ:<a class="ticker" href="/stock/HJLI#NASDAQ">HJLI</a>) rose 12.1% to $12.04 in pre-market trading after the company reported &quot;significant improvements&quot; in all study endpoints for final VenoValve first-in-human data.</li>
	<li>American Outdoor Brands, Inc. (NASDAQ:<a class="ticker" href="/stock/AOUT#NASDAQ">AOUT</a>) shares rose 11.7% to $17.70 in pre-market trading after the company reported upbeat Q2 results and issued strong FY21 forecast.</li>
	<li>Cellectis S.A. (NASDAQ:<a class="ticker" href="/stock/CLLS#NASDAQ">CLLS</a>) rose 10.3% to $28.52 in pre-market trading. Cellectis shares fell 17% on Tuesday after the company reported a $100 million ADS offering.</li>
	<li>Hexindai Inc. (NASDAQ:<a class="ticker" href="/stock/HX#NASDAQ">HX</a>) rose 10.3% to $2.89 in pre-market trading after the company reported the sale of its P2P business for RMB 5 million.</li>
	<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="/stock/LQDA#NASDAQ">LQDA</a>) rose 9.6% to $3.20 in pre-market trading. Liquidia, on Monday, reported a CEO transition.</li>
	<li>New Providence Acquisition Corp. (NYSE:<a class="ticker" href="/stock/NPA#NYSE">NPA</a>) rose 9.6% to $11.31 in pre-market trading.</li>
	<li>R. R. Donnelley &amp; Sons Company (NYSE:<a class="ticker" href="/stock/RRD#NYSE">RRD</a>) shares rose 9.1% to $1.92 in pre-market trading after gaining over 9% on Tuesday. R.R. Donnelley, last week, reported a vaccination distribution toolkit to support marketing and operations for pending COVID-19 vaccine.</li>
	<li>Good Times Restaurants Inc (NASDAQ:<a class="ticker" href="/stock/GTIM#NASDAQ">GTIM</a>) rose 8.1% to $2.13 in pre-market trading after reporting a rise in Q4 earnings.</li>
	<li>DAVIDsTEA Inc. (NASDAQ:<a class="ticker" href="/stock/DTEA#NASDAQ">DTEA</a>) rose 8% to $2.16 in pre-market trading after the company swung to a profit in the third quarter.</li>
	<li>Apollo Endosurgery, Inc. (NASDAQ:<a class="ticker" href="/stock/APEN#NASDAQ">APEN</a>) rose 7% to $4.13 in pre-market trading after the company disclosed that it has received the FDA clearance for the X-Tack Endoscopic HeliX Tacking System.</li>
	<li>Allied Esports Entertainment Inc. (NASDAQ:<a class="ticker" href="/stock/AESE#NASDAQ">AESE</a>) rose 6.7% to $1.75 in pre-market trading after gaining around 9% on Tuesday.</li>
	<li>Polar Power, Inc. (NASDAQ:<a class="ticker" href="/stock/POLA#NASDAQ">POLA</a>) rose 6.7%to $5.00 in pre-market trading after gaining 20% on Tuesday.</li>
	<li>WISeKey International Holding AG (NASDAQ:<a class="ticker" href="/stock/WKEY#NASDAQ">WKEY</a>) rose 6.4% to $5.83 in pre-market trading. WISeKey International, on Monday, reported the launch of IoT partnerships via the Trust Protocol Association to monetize its intellectual property portfolio, including both patent and data assets.</li>
	<li>Immutep Limited (NASDAQ:<a class="ticker" href="/stock/IMMP#NASDAQ">IMMP</a>) rose 5.5% to $3.64 in pre-market trading. Immutep shares gained 15% on Tuesday after the company issued an update on 6 clinical trials.</li>
	<li>BioCardia, Inc. (NASDAQ:<a class="ticker" href="/stock/BCDA#NASDAQ">BCDA</a>) rose 5.4% to $7.06 in pre-market trading after climbing around 50% on Tuesday. BioCardia reported a 1.789 million share registered direct offering priced at $4.75 per share. The company recently said it anticipates data safety monitoring board verbal feedback by the end of Dec. 15 for its pivotal Phase 3 CardiAMP Heart Failure Trial.</li>
	<li>Baidu, Inc. (NASDAQ:<a class="ticker" href="/stock/BIDU#NASDAQ">BIDU</a>) rose 4.6% to $194.02 in pre-market trading. Baidu shares surged around 14% on Tuesday following reports of the Chinese search giant&#39;s interest in the lucrative field of electric vehicle manufacturing.</li>
</ul>

 
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>vTv Therapeutics Inc. (NASDAQ:<a class="ticker" href="/stock/VTVT#NASDAQ">VTVT</a>) fell 26.6% to $2.18 in pre-market trading. VTv Therapeutics, on Tuesday, announced it entered into a licensing agreement with Anteris Bio for worldwide rights to vTv&#39;s novel clinical-stage Nrf2 activator compound, HPP971.</li>
	<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="/stock/CCM#NYSE">CCM</a>) shares fell 24.7% to $4.00 in pre-market trading after surging over 179% on Tuesday.</li>
	<li>Galapagos NV (NASDAQ:<a class="ticker" href="/stock/GLPG#NASDAQ">GLPG</a>) fell 15.4% to $101.11 in pre-market trading after after its partner Gilead said it will not pursue the U.S. FDA Approval of its rheumatoid arthritis treatment filgotinib.</li>
	<li>ENDRA Life Sciences Inc. (NASDAQ:<a class="ticker" href="/stock/NDRA#NASDAQ">NDRA</a>) fell 14.4% to $0.6980 in pre-market trading after the company reported pricing of public offering of common stock.</li>
	<li>Xcel Brands, Inc. (NASDAQ:<a class="ticker" href="/stock/XELB#NASDAQ">XELB</a>) fell 14.4% to $1.13 in pre-market trading after surging around 19% on Tuesday.</li>
	<li>Penumbra, Inc. (NYSE:<a class="ticker" href="/stock/PEN#NYSE">PEN</a>) fell 11.6% to $167.00 in pre-market trading after the company announced it is voluntarily recalling all configurations of the Penumbra JET 7 Reperfusion Catheter with Xtra Flex technology.</li>
	<li>ChromaDex Corporation (NASDAQ:<a class="ticker" href="/stock/CDXC#NASDAQ">CDXC</a>) fell 10% to $4.70 in pre-market trading.</li>
	<li>Mid-Con Energy Partners, LP (NASDAQ:<a class="ticker" href="/stock/MCEP#NASDAQ">MCEP</a>) fell 10% to $3.78 in pre-market trading after climbing 11% on Tuesday.</li>
	<li>Greenwich LifeSciences, Inc. (NASDAQ:<a class="ticker" href="/stock/GLSI#NASDAQ">GLSI</a>) shares fell 9.9% to $47.65 in pre-market trading after the company files for offering of 470,085 shares of its common stock. Greenwich LifeSciences shares jumped 13% on Tuesday after the company announced it entered an option agreement with Westport Bio to in-license a pre-clinical coronavirus vaccine program.</li>
	<li>Patriot Transportation Holding, Inc. (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) fell 9.1% to $11.00 in pre-market trading.</li>
	<li>GeoVax Labs, Inc. (NASDAQ:<a class="ticker" href="/stock/GOVX#NASDAQ">GOVX</a>) fell 7.9% to $3.40 in pre-market trading after climbing around 14% on Tuesday. GeoVax, last month, reported a license agreement with NIH To &#39;support continued advancements in vaccine development.&#39;</li>
	<li>Anchiano Therapeutics Ltd. (NASDAQ:<a class="ticker" href="/stock/ANCN#NASDAQ">ANCN</a>) fell 7.3% to $2.67 in pre-market trading. Anchiano Therapeutics shares jumped 87% on Tuesday after the company announced a merger agreement with Chemomab.</li>
	<li>iQIYI, Inc. (NASDAQ:<a class="ticker" href="/stock/IQ#NASDAQ">IQ</a>) fell 7.2% to $20.70 in pre-market trading as the company after the company announced a proposed offering of convertible senior notes and American Depositary Shares.</li>
	<li>Verastem, Inc. (NASDAQ:<a class="ticker" href="/stock/VSTM#NASDAQ">VSTM</a>) fell 6.8% to $2.06 in pre-market trading. Verastem Oncology, on Tuesday, initiated Phase 2 registration-directed trial of VS-6766 and defactinib in previously treated KRAS mutant non-small cell lung cancer.</li>
	<li>Apartment Investment and Management Company (NYSE:<a class="ticker" href="/stock/AIV#NYSE">AIV</a>) fell 6.7% to $4.70 in pre-market trading. Apartment Investment and Management shares tumbled 86% on Tuesday after the company announced it completed the separation of its businesses, making Apartment Income REIT a separate, publicly-traded company.</li>
	<li>SharpSpring, Inc. (NASDAQ:<a class="ticker" href="/stock/SHSP#NASDAQ">SHSP</a>) fell 6.7% to $14.80 in pre-market trading after reporting a proposed offering of common stock.</li>
	<li>Recro Pharma, Inc. (NASDAQ:<a class="ticker" href="/stock/REPH#NASDAQ">REPH</a>) shares fell 6.6% to $2.83 in pre-market trading after declining around 12% on Tuesday.</li>
	<li>DISH Network Corporation (NASDAQ:<a class="ticker" href="/stock/DISH#NASDAQ">DISH</a>) fell 4% to $34.30 in pre-market trading following news of a convertible notes offering.</li>
</ul>

46 Stocks Moving in Wednesday's Pre-Market Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Code Chain New Continent (NASDAQ:<a class="ticker" href="/stock/CCNC#NASDAQ">CCNC</a>) stock moved upwards by 8.89% to $2.08 during Wednesday&#39;s pre-market session. The company&#39;s market cap stands at $60.6 million.</li>
	<li>R.R.Donnelley &amp; Sons (NYSE:<a class="ticker" href="/stock/RRD#NYSE">RRD</a>) stock increased by 7.95% to $1.9. The company&#39;s market cap stands at $135.6 million.</li>
	<li>Polar Power (NASDAQ:<a class="ticker" href="/stock/POLA#NASDAQ">POLA</a>) shares increased by 7.9% to $5.05. The company&#39;s market cap stands at $58.8 million.</li>
	<li>Safe Bulkers (NYSE:<a class="ticker" href="/stock/SB#NYSE">SB</a>) shares moved upwards by 6.89% to $1.24. The market value of their outstanding shares is at $126.6 million.</li>
	<li>Interface (NASDAQ:<a class="ticker" href="/stock/TILE#NASDAQ">TILE</a>) shares increased by 6.68% to $9.9. The company&#39;s market cap stands at $580.8 million.</li>
	<li>Flux Power Holdings (NASDAQ:<a class="ticker" href="/stock/FLUX#NASDAQ">FLUX</a>) stock rose 5.18% to $12.99. The company&#39;s market cap stands at $155.3 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) stock decreased by 7.44% to $11.2 during Wednesday&#39;s pre-market session. The market value of their outstanding shares is at $37.8 million.</li>
	<li>Quad/Graphics (NYSE:<a class="ticker" href="/stock/QUAD#NYSE">QUAD</a>) shares declined by 5.11% to $3.72. The market value of their outstanding shares is at $199.6 million.</li>
	<li>ATIF Holdings (NASDAQ:<a class="ticker" href="/stock/ATIF#NASDAQ">ATIF</a>) stock decreased by 2.51% to $0.7. The company&#39;s market cap stands at $35.9 million.</li>
	<li>ReneSola (NYSE:<a class="ticker" href="/stock/SOL#NYSE">SOL</a>) shares declined by 1.96% to $8.02. The company&#39;s market cap stands at $430.8 million.</li>
</ul>

&nbsp;

&nbsp;

10 Industrials Stocks Moving In Wednesday's Pre-Market Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Castor Maritime (NASDAQ:<a class="ticker" href="/stock/CTRM#NASDAQ">CTRM</a>) stock increased by 60.99% to $0.37 during Thursday&#39;s pre-market session. The market value of their outstanding shares is at $49.1 million.</li>
	<li>Capstone Turbine (NASDAQ:<a class="ticker" href="/stock/CPST#NASDAQ">CPST</a>) stock increased by 9.28% to $12.0. The market value of their outstanding shares is at $132.8 million.</li>
	<li>HC2 Holdings (NYSE:<a class="ticker" href="/stock/HCHC#NYSE">HCHC</a>) stock rose 7.71% to $3.63. The company&#39;s market cap stands at $278.0 million.</li>
	<li>SG Blocks (NASDAQ:<a class="ticker" href="/stock/SGBX#NASDAQ">SGBX</a>) shares moved upwards by 5.08% to $5.99. The company&#39;s market cap stands at $51.4 million.</li>
	<li>Pyxis Tankers (NASDAQ:<a class="ticker" href="/stock/PXS#NASDAQ">PXS</a>) shares increased by 4.82% to $0.96. The company&#39;s market cap stands at $20.7 million.</li>
	<li>TOMI Environmental Solns (NASDAQ:<a class="ticker" href="/stock/TOMZ#NASDAQ">TOMZ</a>) stock rose 4.55% to $5.05. The market value of their outstanding shares is at $84.6 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) stock decreased by 24.88% to $9.0 during Thursday&#39;s pre-market session. The company&#39;s market cap stands at $30.3 million.</li>
	<li>Lydall (NYSE:<a class="ticker" href="/stock/LDL#NYSE">LDL</a>) shares fell 5.23% to $28.68. The market value of their outstanding shares is at $508.5 million.</li>
	<li>ShiftPixy (NASDAQ:<a class="ticker" href="/stock/PIXY#NASDAQ">PIXY</a>) stock fell 3.55% to $2.45. The company&#39;s market cap stands at $51.2 million.</li>
	<li>JanOne (NASDAQ:<a class="ticker" href="/stock/JAN#NASDAQ">JAN</a>) shares fell 3.5% to $5.25. The market value of their outstanding shares is at $9.6 million.</li>
	<li>ABB (NYSE:<a class="ticker" href="/stock/ABB#NYSE">ABB</a>) stock declined by 2.26% to $27.3. The market value of their outstanding shares is at $56.2 billion.</li>
	<li>Fuel Tech (NASDAQ:<a class="ticker" href="/stock/FTEK#NASDAQ">FTEK</a>) stock fell 1.86% to $4.15. The company&#39;s market cap stands at $102.5 million.</li>
</ul>

&nbsp;

&nbsp;

12 Industrials Stocks Moving In Thursday's Pre-Market Session

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>P &amp; F Industries (NASDAQ:<a class="ticker" href="/stock/PFIN#NASDAQ">PFIN</a>) stock moved upwards by 13.54% to $5.7 during Thursday&#39;s regular session. Trading volume for this security as of 12:31 EST is 549.6K, which is 9854.54% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.9 million.</li>
	<li>Seanergy Maritime Hldgs (NASDAQ:<a class="ticker" href="/stock/SHIP#NASDAQ">SHIP</a>) stock rose 11.96% to $0.56. As of 12:31 EST, this security is trading at a volume of 25.1 million shares, making up 403.27% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.4 million.</li>
	<li>Maxar Technologies (NYSE:<a class="ticker" href="/stock/MAXR#NYSE">MAXR</a>) stock moved upwards by 11.04% to $38.98. Maxar Technologies&#39;s stock is trading at a volume of 1.0 million shares as of 12:31 EST. This is 89.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.3 billion.</li>
	<li>ATIF Holdings (NASDAQ:<a class="ticker" href="/stock/ATIF#NASDAQ">ATIF</a>) stock moved upwards by 7.88% to $1.0. ATIF Holdings&#39;s stock is trading at a volume of 20.9 million shares as of 12:31 EST. This is 460.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.3 million.</li>
	<li>Grindrod Shipping Hldgs (NASDAQ:<a class="ticker" href="/stock/GRIN#NASDAQ">GRIN</a>) shares increased by 7.69% to $4.2. The current volume of 26.7K shares is 131.31% of Grindrod Shipping Hldgs&#39;s average full-day volume over the last 100 days (last updated at 12:31 EST). The market value of their outstanding shares is at $79.8 million.</li>
	<li>Beam Global (NASDAQ:<a class="ticker" href="/stock/BEEM#NASDAQ">BEEM</a>) shares increased by 7.35% to $72.95. Beam Global&#39;s stock is trading at a volume of 601.8K shares as of 12:31 EST. This is 91.87% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $581.5 million.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) shares decreased by 25.91% to $8.88 during Thursday&#39;s regular session. Patriot Transportation&#39;s stock is trading at a volume of 107.0K shares as of 12:31 EST. This is 603.08% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $29.9 million.</li>
	<li>Castor Maritime (NASDAQ:<a class="ticker" href="/stock/CTRM#NASDAQ">CTRM</a>) stock declined by 18.78% to $0.19. Trading volume for this security as of 12:31 EST is 245.2 million, which is 1855.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $24.8 million.</li>
	<li>Orbital Energy Group (NASDAQ:<a class="ticker" href="/stock/OEG#NASDAQ">OEG</a>) shares decreased by 16.39% to $1.97. Trading volume for this security as of 12:31 EST is 4.9 million, which is 114.9% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $59.7 million.</li>
	<li>JanOne (NASDAQ:<a class="ticker" href="/stock/JAN#NASDAQ">JAN</a>) stock decreased by 10.85% to $4.85. Trading volume for this security as of 12:31 EST is 371.6K, which is 150.37% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $8.8 million.</li>
	<li>Pyxis Tankers (NASDAQ:<a class="ticker" href="/stock/PXS#NASDAQ">PXS</a>) shares fell 7.33% to $0.85. The current volume of 821.1K shares is 123.65% of Pyxis Tankers&#39;s average full-day volume over the last 100 days (last updated at 12:31 EST). The company&#39;s market cap stands at $18.3 million.</li>
	<li>CBAK Energy Technology (NASDAQ:<a class="ticker" href="/stock/CBAT#NASDAQ">CBAT</a>) stock decreased by 6.91% to $5.12. As of 12:31 EST, CBAK Energy Technology&#39;s stock is trading at a volume of 2.0 million, which is 19.42% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $406.0 million.</li>
</ul>

&nbsp;

&nbsp;

Patriot Transportation (NASDAQ:<a class="ticker" href="/stock/PATI#NASDAQ">PATI</a>) reported quarterly losses of $(0.07) per share. This is a 50 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $20.23 million which missed the analyst consensus estimate of $30.00 million by 32.57 percent. This is a 18.46 percent decrease over sales of $24.81 million the same period last year.

Patriot Transportation Q1 EPS $(0.07) Up From $(0.14) YoY, Sales $20.23M Miss $30.00M Estimate

&nbsp;

<h3>Gainers</h3>

<ul>
	<li>Flux Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) shares rose 13.13% to $8.7 during Thursday&#39;s regular session. The current volume of 439.5K shares is 251.16% of Flux Power Holdings&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $113.1 million. The company&#39;s, Q3 earnings came out today.</li>
	<li>Charah Solns (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHRA#NYSE">CHRA</a>) shares rose 8.79% to $5.69. Charah Solns&#39;s stock is trading at a volume of 231.4K shares as of 12:30 EST. This is 118.49% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $173.1 million. The company&#39;s, Q1 earnings came out yesterday.</li>
	<li>Cornerstone Building (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>) stock rose 8.25% to $14.62. Trading volume for Cornerstone Building&#39;s stock is 834.6K as of 12:30 EST. This is 87.16% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.8 billion. The company&#39;s, Q1 earnings came out 2 days ago.</li>
	<li>Blue Bird (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) stock increased by 8.24% to $26.78. Trading volume for Blue Bird&#39;s stock is 153.4K as of 12:30 EST. This is 58.39% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $726.0 million. As per the news, the Q2 earnings report came out yesterday.</li>
	<li>Applied UV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUVI#NASDAQ">AUVI</a>) stock rose 7.74% to $7.65. As of 12:30 EST, Applied UV&#39;s stock is trading at a volume of 246.2K, which is 37.66% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $71.9 million.</li>
	<li>Fuel Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEK#NASDAQ">FTEK</a>) stock moved upwards by 7.11% to $2.08. Trading volume for Fuel Tech&#39;s stock is 36.3 million as of 12:30 EST. This is 5461.03% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $62.8 million. The company&#39;s, Q1 earnings came out yesterday.</li>
</ul>

&nbsp;

&nbsp;

<h3>Losers</h3>

&nbsp;

<ul>
	<li>Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) shares declined by 19.24% to $19.2 during Thursday&#39;s regular session. The current volume of 7.4 million shares is 308.64% of Fluor&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $2.7 billion. As per the press release, Q1 earnings came out 4 days ago.</li>
	<li>Montrose Environmental Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEG#NYSE">MEG</a>) stock fell 13.28% to $46.9. Trading volume for this security as of 12:30 EST is 264.9K, which is 108.33% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $1.2 billion. The company&#39;s, Q1 earnings came out yesterday.</li>
	<li>Patriot Transportation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PATI#NASDAQ">PATI</a>) shares decreased by 11.36% to $11.57. As of 12:30 EST, Patriot Transportation&#39;s stock is trading at a volume of 15.5K, which is 164.42% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $39.0 million.</li>
	<li>Beam Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEEM#NASDAQ">BEEM</a>) shares decreased by 10.31% to $21.75. The current volume of 446.3K shares is 92.36% of Beam Global&#39;s average full-day volume over the last 100 days (last updated at 12:30 EST). The company&#39;s market cap stands at $192.8 million. The company&#39;s, Q1 earnings came out today.</li>
	<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) shares decreased by 9.03% to $9.12. As of 12:30 EST, this security is trading at a volume of 1.0 million shares, making up 90.02% of its average full-day volume over the last 100 days. The company&#39;s market cap stands at $374.0 million. As per the press release, Q1 earnings came out 3 days ago.</li>
</ul>

&nbsp;

&nbsp;

11 Industrials Stocks Moving In Thursday's Intraday Session

Patriot Transportation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PATI#NASDAQ">PATI</a>) reported quarterly earnings of $0.14 per share. This is a 216.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported $18.22 million in sales this quarter. This is a 22.54 percent decrease over sales of $23.53 million the same period last year.

Q3 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-07-28
REV		(EXPECTED)2021-07-28

Q2 2021		Est.		Actual		Surprise
EPS				-0.160
REV		30.000M		19.728M		-10.272M

Recent Quotes

Earnings

Related Companies

Patriot Transportation Frequently Asked Questions

How do I buy Patriot Transportation (PATI) stock?

Who are Patriot Transportation's (PATI) competitors?

What is the target price for Patriot Transportation (PATI) stock?

Current Stock Price for Patriot Transportation (PATI)?

Does Patriot Transportation (PATI) pay a dividend?

When is Patriot Transportation (NASDAQ:PATI) reporting earnings?

Is Patriot Transportation (PATI) going to split?

What sector and industry does Patriot Transportation (PATI) operate in?